Regulation of Cardiac Progenitors by Combination of Mesp1 and ETS Transcription Factors by Weng, Kuo-Chan
  
 
 
REGULATION OF CARDIAC PROGENITORS BY COMBINATION OF MESP1 
AND ETS TRANSCRIPTION FACTORS 
 
A Dissertation 
by 
KUO-CHAN WENG  
 
Submitted to the Office of Graduate and Professional Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of 
DOCTOR OF PHILOSOPHY 
 
 
Chair of Committee,  Fen Wang 
Co-Chair of Committee, Robert J. Schwartz 
Committee Members, James F. Martin 
 Jiang Chang 
Head of Department, Fen Wang 
 
May 2014 
 
 
Major Subject: Medical Science 
 
 
Copyright 2014 Kuo-Chan Weng
 ii 
 
ABSTRACT 
 
Heart disease remains the leading cause of death worldwide. By understanding the 
regulating networks during cardiac development we can exploit those networks to 
manipulate adult cells into cardiac progenitors and provide an alternative for repairing 
diseased hearts. Mesp1 is considered to have critical roles during cardiac development but 
the molecular mechanisms need to be further studied. The roles of ETS transcription 
factors have been primarily limited to hematopoietic differentiation and cancer 
progression. The ETS transcription factors are known to have proliferating roles and were 
hypothesized to also be involved in cardiac differentiation and may potentially be used for 
cell reprogramming. 
 
The first part of this study characterizes the expression pattern of Mesp1 protein in early 
mouse embryo from E6.5 to E9.5 and provides a full expression profile in differentiating 
embryoid bodies in vitro from the undifferentiated stage to Day10. Our work showed 
Mesp1 expresses in the posterior region of E6.5 embryo then starts migrating through the 
primitive streak toward anterior mesoderm and endoderm in E7.5. A Mesp1 linage tracing 
ES cell line was established, and it allowed us to trace the Mesp1 derived cell population. 
The lineage tracing system confirmed Mesp1 expressing cells give rise to a major part of 
the heart and also contributes to some endodermal derived organs such as the pancreas. 
The direct DNA binding targets of Mesp1 were determined using a Mesp1 specific 
antibody to perform ChIP of bound DNA that could then be used in next generation 
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sequencing. The resulting sequence data included cardiac genes such as Gata4, Hand2, 
and Myocd. Endoderm correlated genes Foxa2, Pitx2, and Gata6 were also shown to be 
Mesp1 targets. The targeted genes were validated as transcriptional targets using an ES 
cell line with inducible Mesp1 followed by qPCR of target gene transcript levels with and 
without Mesp1 expression. Secondly, the complete gene expression profiles of over 20 
ETS transcription factors were generated. By comparing the ETS factor expression 
patterns and identifying which showed cardiac gene activation, ETV4 and ETS2 were 
chosen for further study of their roles in cardiac differentiation. ETS2 was used in 
combination with Mesp1 to reprogram Normal Human Dermal Fibroblast into cardiac 
progenitors. The reprogrammed cells were then characterized for gene expression 
patterns, surface marker, and structural protein presentation. This work provides thorough 
insights into the roles of Mesp1 and ETS transcription factors during germ layer 
development and led to the development of a method to reprogram adult cells into cardiac 
progenitors that could be applied for clinical use in the future. 
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1. INTRODUCTION 
 
1.1 Overview of Cardiovascular Diseases 
1.1.1 Cardiovascular Diseases Remain Leading Cause of Mortality 
Cardiovascular disease remains the leading cause of death in women and men across the 
world.  Even with the exponential advances over the past decade in medicine and clinical 
treatment options for treating heart disease, the cardiac related deaths still has the highest 
mortality rate. There is also an increasing number of heart disease related cases in both 
developmental and low-income countries[1]. In 2010, people in the USA spent $315 
billion on medical treatments for cardiovascular diseases alone. However, the rate of 
cardiac related deaths has not decreased and the majority of current treatment options 
merely manage heart disease and are unable to cure it[2]. 
 
The major cause of cardiovascular diseases is ischemic heart disease (IHD) or coronary 
artery disease (CAD)[3]. It is triggered by plaque accumulation in the inner wall of the 
coronary artery, which leads to a loss of oxygen and nutrients that are necessary for 
proper cardiomyocyte function[4]. Through the progression of CAD, the patient may 
suffer from angina and eventually suffer a heart attack. The acute heart disease causes 
the irreversible loss of cardiomyocytes that could lead to permanent heart failure and 
immediate death if not instantly treated[5]. 
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There are different treatments for myocardial infarctions including surgical repairs, 
physical therapy, and heart transplants[6, 7]. Those patients, where a transplant is the 
only remaining option, face major challenges after receiving the new heart. The patients 
need to take immunosuppressive drug to reduce the transplant rejection by their own 
immune system and the long term use of these drugs may lead to developing a fatal 
infection[8, 9]. The long term prognoses are not ideal even with modern technologies 
and patient care. The 5-year survival rate of patients with a heart transplant is less than 
75% according to American Heart Association[10]. The shortage of heart donors is also 
a major obstacle along with the chance an available heart is suitable for the recipient in 
need. Therefore, alternative methods are needed to treat patients who are waiting for a 
heart transplant  
 
1.1.2 Limited Ability of Regeneration of Cardiomyocytes in Adult Heart 
The regeneration of cardiomyocytes only happens in vertebrate such as Zebrafish and 
amphibians[11, 12]. Mammalian heart are terminally differentiated and are considered to 
have poor regenerative ability[13, 14]. However, a recent report showed the heart in 
neonatal mice could regenerate after heart surgical resection[15]. The ventricular apex of 
neonatal mice was resected and the full restoration was observed after 21 days. The 
regenerated regions were revealed to originate from pre-existing cardiomyocytes. This 
study means the mammalian heart may have regeneration capacity during younger ages. 
Another group demonstrated the turnover of cardiomyocytes in adult mice might occur 
at very low rates[16]. This means the mature myocardium of the heart can be replaced 
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either by an existing cardiac stem cell pool or by recruiting stem cells through 
circulation. Moreover, the studies showed the population of cardiomyocytes was altered 
after injury. This newly generated population was from the proliferation of an existing 
pool of cardiac progenitors around the injured region[17].  
 
The regeneration of cardiomyocytes from a pre-existing population revealed that the 
signaling pathways involved in this process are important for identifying new therapies. 
The pathways involved in cell proliferation and differentiation are usually highly 
conserved throughout the developmental stages. They include BMP, FGF, Wnt and 
Nodal signaling pathways. To better understanding how cardiomyocytes could be 
repaired, researchers look to cardiac development during the embryonic stage to help us 
to focus on the critical factors involved throughout the developmental and repair process.  
 
1.2 Heart Development 
1.2.1 Embryo Development 
Embryonic development starts from a single, fertilized cell embryo that undergoes 
cleavage division to become a blastomere that progresses to an egg cylinder before 
becoming a  gastrula that continues to go through asymmetrical proliferation and 
distinctive germ layer differentiation that blossoms into a complex, three dimensional 
organism[18]. The gastrulation stage is one of the most important processes in early 
mouse embryogenesis. The cells divide into three germ layers: ectoderm, mesoderm, and 
endoderm. The three germ layers will later contribute to tissue development. The 
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majority of the ectoderm layer will develop into the neural system, skin, and tooth 
enamel. Mesoderm derives cardiac muscle, skeletal muscle, and blood cells[19]. 
Endoderm becomes the gastrointestinal tract, respiratory tract, and endocrine organs[20]. 
The work presented here, focuses on mesoderm and endoderm development. 
 
The endoderm layer will give rise to organs such as the digestive tract and respiratory 
tube. This includes the mouth, pharynx, trachea, lungs, urinary bladder, thyroid gland, 
and thymus. There are three components of the mesoderm germ layer: the paraxial 
mesoderm, the intermediate mesoderm, and the lateral plate mesoderm. The paraxial 
mesoderm will form somitomeres and later give rise to muscle tissue, cartilage, bone, 
and subcutaneous, skin tissue. The intermediate mesoderm in the upper thoracic and 
cervical regions forms the nephrotome, and in caudally regions it forms the nephrogenic 
cord. The lateral plate mesoderm splits into somatic and splanchnic layers. The somatic 
layer will form the lateral body wall that folds with the ectoderm and the splanchnic 
layer will form the walls of gut tube. 
 
1.2.2 Heart Formation  
Heart is derived from the mesoderm germ layer during embryonic development[21]. At 
E5.0, Nodal signaling induces the mesoderm in proximal epiblast and allows Bmp4 
expression in the extraembryonic ectoderm. The expression of Bmp4 keeps Wnt3 
expression in the proximal epiblast. At E5.5, the Wnt inhibitors Dkk1, Lefty1, and Cer1 
are expressed in the anterior region so that they restrict the Wnt and Nodal signaling in 
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the posterior epiblast. Wnt signaling induces mesodermal marker T (Brachyury) and 
Eomes expression in E5.75 that will later induce Mesp1 expression to drive cardiac, 
mesoderm specification through Dkk1-mediated inhibition of Wnt pathway[22]. 
 
The cardiac mesoderm will give rise to endocardium, the first heart field (FHF) and the 
second heart field (SHF). The first heart field will form the left ventricle, atria, and 
conduction system whereas the second heart field will give rise to the right ventricle, 
part of atria, and outflow tract[23]. The transcription networks coordinate the formation 
of the heart during development. This includes the transcription factors, Nkx2-5, Gata4, 
Tbx20, found in both heart fields and Hand2, Isl1, Mef2c, and Fgf10 found in the second 
heart field[24]. Knocking out these genes usually leads to embryonic lethality and/or a 
defect of cardiac morphogenesis[25]. At E9.5, the cardiac crescent forms a looping heart 
tube through rightward looping. The cardiac neural crest migrates into the outflow tract 
and separates and configures the aortic arch arteries[26]. Later, the heart forms four 
chambers at E10.5[27, 28]. 
 
1.2.3 Signal Pathways in Cardiac Development 
1.2.3.1 TGF Beta Signaling Pathway  
Transforming Growth Factor beta (TGFB) super family signaling pathway plays critical 
roles during embryo development that includes cell proliferation and cell differentiation. 
The general molecular mechanism of the TGFB pathway is through ligand-receptor 
interactions. The ligands bind on type II TGFB receptors and type II receptors recruit 
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type I receptors. Then the Type I receptors phosphorylate receptor-regulated SMADs (R-
SMAD) and R-SMADs interact with the other coSMAD SMAD4. The R-
SMAD/coSMAD complex then translocates to the nucleus to regulate downstream target 
genes.  
 
The ligands include Bone Morphogenetic Proteins (BMPs), Activin, Nodal, and TGF. 
BMPs bind to type II receptor BMPR2 and activate SAMD1, 5, and 8 through type I 
receptor BMPR1A (ALK3) and BMPR1B (ALK6) and the ligands can be inhibited by 
Noggin and Chordin. Nodal binds to ACVR2B and activates SMADs through ACVR1B 
(ALK4) or ACVR1C (ALK7) and can be inhibited by Lefty. TGFs bind to TGFRII 
and activate SMADs through TGFRI (ALK5). Activin A binds to ACVR2A and 
activates SMADs through ACVR1B (ALK4) and can be inhibited by Follistatin. 
 
Among BMP lignads, BMP2 and BMP4 can induce cardiomyocyte differentiation[29-
31] and both BMP2 and BMP4 null mice are embryonic lethal[32, 33]. The phenotype of 
BMP4 null mice showed plasticity. It suggested the multiple roles of BMP4 such as 
gastrulation or mesoderm specification. Mice lacking Activin did not show significant 
heart defects while the roles of mesoderm formation had been confirmed in lower 
vertebrates[34]. Only ACVR2B knockout mice showed heart defects on left-right 
patterning[35].  
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1.2.3.2 FGF Signaling Pathway 
Fibroblast growth factors (FGF) are growth factors that play roles in the process of cell 
proliferation, differentiation, and migration[36, 37]. The mitogenic functions include 
mesoderm formation, anterior-posterior patterning, neural development, and wound 
healing[38, 39]. Twenty-two FGF family members in vertebrates have been identified 
and some of them show important roles in cardiac development[40, 41]. The FGF signal 
pathway undergoes downstream signaling by interacting with tyrosine kinase receptors. 
There are four major members of FGF receptors (FGFR1-4). The heterodimerization of 
FGF and FGFR results in phosphorylation of intracellular residue of FGFR and activates 
the signal transduction pathways. Two major signaling cascades include MAPK and 
PI3K cascades[42, 43]. 
 
FGF signaling pathway showed multiple roles in cardiac development. FGF2 (basic 
FGF) plays a critical role  by inducing the expression of important core cardiac 
transcription factors[44]. Fgf4 regulates valve precursor cell proliferation through 
inducing the expansion of cushion mesenchyme[45]. Fgf8 is shown to regulate the out 
flow tract and right ventricle development. Fgf9 is required for myocardial proliferation 
and coronary vascular development. The ablation of FGFR also shows abnormality 
during development. The Fgfr1 knockout mice are lethal during gastrulation showing 
defective mesoderm patterning[46]. 
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1.2.3.3 Notch Signaling Pathway 
Notch signaling pathway is a conserved signaling pathway in multiple cellular organisms 
that plays a role in cell fate specification, differentiation, and patterning. There are four 
types of Notch receptors in mammals: NOTCH1, NOTCH2, NOTCH3, and NOTCH4. 
The Notch receptor consists of a large extracellular domain (NECD), a single-pass 
transmembrane and a shorter intracellular domain (NICD). The extracellular domain can 
interact with the membrane-bound ligands expressed by neighbor cells. The interaction 
depends on the E3 ubiquitination and leads to the endocytosis of ligands and the Notch 
receptors will be cleaved at the S2 site. The remaining Notch receptors were cleaved at 
S3 site by -secretase and release the NICD. The NICD then translocates to the nucleus 
and interacts with transcription factor RBPJ. In the absent of Notch signaling, the RBPJ 
recruit the transcription co-activator MAML and activate the bHLH repressor Hes and 
Hey transcription family. 
 
The expression of Notch pathway starts from E7.5 endocardium. N1ICD and ligand Dll4 
are detectable during this stage[47]. At E8.0, the Notch ligand Jag1 is expressed in 
myocardium and Notch2, Notch4, Dll4, and N1ICD are in endocardium[48-50]. As the 
progression of embryo development continues, the expression of Notch pathway after 
E9.5 showed complex expression to coordinate the looped heart and left-right 
asymmetry. The mutation of factors in Notch pathway usually leads to a congenital heart 
disease such as Alagille syndrome, bicuspid aortic valve disease, and calcification of 
heart valves. The ablation of Dll4 is embryonic lethal at E9.5 and showed reduced atrial 
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and ventricular chambers. Notch1 knockout mice is also embryonic lethal at E10.5 and 
showed hypoplastic cardiac cushions. Overexpression of Notch pathway also showed 
abnormal heart development. Overexpressing N1CID by Mesp1-Cre showed impaired 
ventricular myocardial differentiation and activation of Hey1 by Mesp1-Cre showed 
reduction of atrioventricular canal[51]. 
 
1.2.3.4 Wnt Signaling Pathway 
The Wnt signaling pathways play roles in cell communication, passing signals from 
outside the cellular membrane through surface receptors into cells and can be either 
paracrine or autocrine[52, 53]. Wnt proteins can interact with their signal mediator, β-
catenin. In the absent of Wnt, β-catenin forms complexes with Axin, APC, and GSK and 
is phosphorylated to be subsequently degraded by proteasomes. With the presence of 
Wnt, β-catenin is released from complex and enters the nucleus to regulate downstream 
genes through TCF/LEF transcription factors.  
 
There are three major Wnt pathways: canonical Wnt pathways, non-canonical Wnt/JNK 
planar cell polarity pathways, and non-canonical Wnt/calcium pathways. Canonical Wnt 
pathways mediate cell proliferation through regulating genes such as c-myc and cyclinD1 
[54] and this can be inhibited by Dkk-1[55]. The non-canonical pathways are mediated 
by β-catenin independent signaling cascade. In Wnt/JNK pathways, Wnt signaling is 
carried by Rho-JNK kinase cascade while Wnt/Ca pathways are regulated by 
calmodulin-depend kinase (CaMKII) cascades[56]. The recent reports showed non-
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canonical Wnt pathways could crosstalk to canonical Wnt pathways through different 
mechanisms[57]. 
 
The inhibition of Wnt pathways is essential during myocardial specification. The tissue 
specific ablation of β-catenin leads to the formation of multiple hearts[58]. However, 
there are also reports that suggest the positive roles of Wnt pathways during P19 
teratocarcinoma stem cell differentiation[59]. These controversial results demonstrate 
the complex and multiple functions of Wnt pathways during developmental processes.  
 
1.3 Stem Cell and Research 
1.3.1 Stem Cell Research 
The signaling pathway in mouse heart development showed the complexity of signaling 
pathways. Some genetic ablation mouse model even showed controversial roles. It made 
the research on single factor become impractical. The in vitro stem cell research could 
simplify the roles of individual factor and make manipulating cells easier. It also reduced 
time and costs comparing using animal models. The manipulated stem cells may also 
benefit to experiments such as performing cell therapy in injury model. 
 
The stem cells can be isolated from inner cell mass (ICM) of blastocyst and cultured in 
vivo while maintaining their pluripotency[60, 61]. Stem cells have the differentiate 
potential to cardiomyocytes, neurons, islet cells, and blood cells and are considered very 
high valuable source for basic research and clinical application. Mouse embryonic stem 
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cells (mESC) can be differentiated in vitro by force aggregating. The most established 
way is hanging drop method, a method that aggregate mESC by gravity in a droplet. The 
mESC will form enbryoid body (EB) and EB will beat spontaneously about one week 
after aggregating. Recently report showed expression of Gata4, Tbx5, and Baf60c was 
sufficient to convert noncardiac mesoderm into beating cardiomyocyte[62]. Keller Lab 
also demosrate the optimized treatment of signals such as BMP and Activin could 
promote cardiac differentiation[63]. The stem cell research provides an insight method 
to better understand molecular mechanisms during cardiac development. 
 
1.3.2 Reprogramming Somatic and IPS Cell Types 
The terminally differentiated cells were considered lost the proliferating ability. By 
introducing stem cell associated factors Oct4, Sox2, cMyc, and Klf4, Yamanaka and 
colleagues showed the converting of somatic cell back to pluripotent cells (induced 
pluripotent cells, iPS cells)[64]. This strategy bypasses the potential ethical issue using 
human embryonic stem cells. The iPS cells could provide the source of patient specific 
cells for cell therapies. It could also establish a genetic disease model from patients for 
basic research. 
 
The concept of converting cell fates from one to another (transdifferentiation) had been 
proven successful. People further test whether adult cells can be transdifferentiated 
toward cardiomyocyte or not. Recent report suggested by introducing transcription 
factors Gata4, Mef2c, Tbx5, and Hand2 could transdifferentiate fibroblast into 
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cardiomyocyte[65, 66]. To sum up, manipulating adult cells by introducing exogenous 
genes or essential signaling molecules provide a practical ways to perform stem cell 
therapies. 
 
1.4 Gene Regulations and Transcription Factors 
1.4.1 Gene Regulation 
In multiple cellular organisms, developing cells are surrounded by a constantly changing 
environment. They can receive and be affected by extracellular signals through the 
physical interaction with neighboring cells by secreted molecules from remote cells. 
Developing cells are guided by differing signals to respond to distinct developmental 
cues such as cell proliferation, lineage specification, differentiation, left-right patterning, 
and apoptosis. The progression through development requires that signals quickly find 
and communicate their message to its desired target(s) so that the developmental process 
can be achieved in the right place and right time. This involves the tight and orchestrated 
regulation at the molecular level for cells to be propelled into the stages on development 
and differentiation. 
 
There are several ways to regulate gene expressions including transcriptional regulation, 
post-transcriptional regulation, translational regulation, post-translational regulation, and 
epigenetic regulation. Transcription is usually initiated by the interaction of DNA and 
transcription factors. The transcription factors bind on DNA by recognizing specific 
region and recruit the RNA polymerase near the transcription complex. The RNA 
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polymerase then starts transcription and synthesizes mRNA for protein synthesis. In 
some cases, however, the transcription factors may also function as negative regulators 
by competing for the DNA binding sites with other transcription factors and 
subsequently blocks gene transcription. Post-transcriptional regulation occurs after the 
gene transcript has been made and is blocked from undergoing translation either by 
degradation or by regulatory miRNAs that bind to the 3’UTR of mRNA to prevent the 
ribosomal complex formation. Post-translational regulation is regulating the protein 
activities or half-life by modifying the protein by means of phosphorylation and tagging 
the protein for ubiquitination. Epigenetic regulation means regulating the genes activity 
without changing or directly binding to the DNA sequences but by modifying or 
interacting with the histone protein complexes the DNA is coiled around. By 
manipulating the scaffold in which the DNA strands are coiled around, we can promote 
or prevent a gene’s expression. In this study, we will focus on the transcriptional level of 
gene expression regulation during the developmental process. 
 
1.4.2 Transcription Regulation 
Transcription factors are proteins with DNA binding domains that bind to genomic DNA 
by recognizing a specific sequence motif or genomic structural feature. The DNA 
binding domains recognize specific DNA sequences and the trans-activating domain can 
interact with other protein such as co-activator or co-repressor. The transcription factors 
have been primarily grouped into different TF families based on what their DNA binding 
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domain specifically interacts with such as basic helix-loop-helix, basic-leucine zipper, 
zinc fingers, homeodomain, and helix-turn-helix. 
 
Transcription factors can bind genomic DNA in diverse regions of the genome including 
promoter, enhancer, and intergenic regions. They can also be found within the intron 
regions of other genes. Usually, the promoters are regions that are near the transcription 
start site (TSS) (within 5kb upstream of the start site). Enhancers are genomic regions 
that can promote transcription of a gene that may not be located near the gene’s 
promoter and seem too far from the transcription start site but enhancers can be 
geometrically close and form the transcription complex. The promoters and enhancers of 
genes are usually evolutional conserved and have been intensively studied in 
developmental biology. The transgenic mice consisted of a specific promoter driven 
reporter that was widely used to study the expression pattern of genes. For example, 
Nkx2-5 had been shown to regulate cardiac development. By dissecting the different 
Nkx2-5 upstream regions, several regions were identified to regulate different regions of 
heart including the right atria, right ventricle, cardiac crescent and inter-ventricular 
septum. 
 
1.4.3 The Roles of Mesp1 during Cardiac Development 
Mesp1 is a bHLH (basic helix-loop-helix) transcription factor that was first identified by 
screening enriched transcripts in the posterior region of mouse embryo at E7.5 stage and 
named “mesoderm posterior 1”[67]. The earliest expression in mouse embryo can be 
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detected in the initiation stage of gastrulation around E6.25-6.5 at the junction of epiblast 
and extraembryonic ectoderm. It reaches the highest expression level in nascent 
mesoderm and primitive streak at E6.5-6.75. Mesp1 expression is soon down regulated 
after E7.5 and localized only in the base of allantois. The expression moves from the 
base of allantois to the edge of the tailbud and almost disappears after E8.5. The only 
adult tissue that expresses Mesp1 is mature testis. The Mesp1 lineage tracing was 
designed by using Cre-loxP system. It showed Mesp1 expressing cells ingresses through 
primitive streak and cooperates with the mesodermal part of amnion. It contributed to 
the myocardium but not the endocardium of the later heart. The ablation of Mesp1 is 
embryonic lethal due to cardia bifida. This suggested the essential role of Mesp1 during 
cardiac development. Flk1 expression was accumulated in the posterior region in Mesp1 
deficient mice. Genes that regulated cardiac development such as Hand2 and Gata4, 
however, were not significantly altered[68, 69]. This means the roles of Mesp1 during 
cardiac development is in the specification of cardiac progenitors. However knocking 
out both Mesp1 and Mesp2 leads to the absence of the heart[70]. This result suggested 
the functional role of Mesp1 during cardiac mesoderm development and might be 
compensated by Mesp2 when Mesp1 is lost. 
 
Recent studies of Mesp1 from molecular approaches suggest Mesp1 regulates 
downstream targets through DNA binding on the promoter region of Dkk1, a Wnt 
signaling inhibitor that plays critical roles in cardiovascular differentiation. It is 
suggested that Mesp1 regulates cardiovascular restriction through regulating core cardiac 
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developmental genes such as Gata4, Mef2c, Tbx5, and Hand2. It also regulates 
Epithelial-Mesenchymal Transition (EMT) through induction of Snai1, which agrees the 
roles of Mesp1 during gastrulation of early mouse embryos[71]. A similar study 
suggested that Mesp1 regulates the core cardiac transcription factors also through 
binding to their promoter regions[72]. These molecular studies define Mesp1 as the most 
critical factor for cardiovascular development.  
 
1.4.4 ETS Transcription Factors 
The ETS transcription factors are named after E-twenty-six or E26 transforming specific 
factors. They belong to ETS transcription factor family that all contain an ETS DNA 
binding domain. It was first identified from the gene transduced by E26 leukemia virus. 
The ETS transcription factors were reported to be associated with cancer progression in 
different tissues. The DNA binding ETS domain is an evolutionally conserved region 
that recognizes DNA specifically through a common sequence GGA(A/T). Besides the 
ETS domain, some ETS transcription factors consist of conserved PNT (Pointed) 
domain, which could associate with potential binding partners to regulate different 
genes. 
 
The expression patterns of all ETS transcription factors in human tissues and cell lines 
are ubiquitous. There were 16 ETS transcription factors expressed in all tissues and more 
than half of all ETS transcription factors were considered as ubiquitous. The mRNA 
level may not be the best way to identify tissue specific ETS transcription factors. 
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However, some ETS transcription factors are highly expressed in certain tissues. For 
example, ERG and FLI1 expression is higher in endothelial cells, which explains their 
roles in endothelial development[73, 74]. Another example is PEA3 families that are 
highly expressed in cancer cell lines, which match their roles in tumor progression. 
 
Although ETS transcription factors all bind a similar DNA sequence, GGA(A/T), the 
genome wide ChIP (chromatin immunoprecipitation) arrays or ChIP-sequencing results 
provide the detailed binding specificities of different ETS transcription factors in 
different tissues. One report showed the binding regions of GABPA in Jurkat cells were 
also occupied by ETS1. The shared regions bound by different ETS transcription factors 
are often located in the promoters of house-keeping genes. However, the DNA binding 
sequences were also reported to be specific for only some ETS transcription factors. For 
example, ERG and FLI1 shared redundant groups of genes while SPI1 was less 
overlapping with these regions in hematopoietic stem cells. 
 
The ETS transcription factors could also regulate target genes through thr combination 
of different association partners within transcription complexes. The interactions of 
Serum Response Factors (SRF) and TCF subfamily member such as ELK1, ELK3, and 
ELK4 have been well studied. The co-occupancy of genomic regions by ETS1 and 
RUNX1 was characterized and the target genes regulated by this interaction were 
ZAP70, CXCR4, and CD38 during T cell activation. These studies demonstrated the 
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multiple roles of ETS transcription factors during the developmental process of different 
tissues. 
 
The ETS transcription factors may play multiple roles during embryo development. The 
following are some examples how ETS transcription factors regulate cardiovascular 
development. ETS-related protein 71 (Etsrp71, human ETV2) is expressed in 
endothelium and endocardium of the developing heart. It was shown that Nkx2-5 binds 
to the promoter regions of ETV2 and the ablation of Nkx2-5 causes down regulation of 
ETV2 and leads to embryonic lethality. The regulation of ETV2 during cardiac 
development was shown through direct regulation of Tie2 expression. It was also shown 
that the cardiac gene Mef2c could be regulated by the combination of Etv2 and Foxc2. 
Combination of Etv2 and Foxc2 activate Flk1 expression in Xenopus embryos and is 
also required for vascular development in Zebrafish. These studies provide evidence that 
ETS transcription factors could be involved in regulating cardiac development through 
the combination of assembling proteins in the nearby regulatory, chromatin regions or in 
the transcription complexes. 
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2. MATERIALS AND METHODS 
 
2.1 Embryonic Stem Cell Culture 
Mouse embryonic stem (ES) cell line, AB2.2, was purchased from ATCC (American 
Type Culture Collection) and stored in liquid nitrogen until ready for use. Dr. Yu Liu 
from the University of Houston generated UH3 cell line used throughout this work. Dr. 
Yu Liu from the University of Houston also generated Mesp1 doxycycline inducible ES 
cells. To be brief, AB2.2 cells were infected with the lentivirus carrying inducible 
Mesp1 construct and the lentivirus carrying rtTA (Tet-on 3G trans-activator) construct. 
ES cells were put under puromycin selection to obtain a stable cell line with the desired 
construct. 
 
Cells were grown with M15 ES growth media that is DMEM (SH30022, HyClone) 
supplemented with 15% ES defined fetal bovine serum (FBS) (SH30070.03, HyClone), 
L-Glutamine (25030, Gibco), Penicillin-Streptomycin (15140 Gibco), 100 mM of -
mercaptoethanol (M7522, Sigma Aldrich). ES cells were sub-cultured every other day 
and media changed daily supplemented with 1000 U/ mL of LIF (ESG1107, Millipore) 
to maintain pluripotency.  
 
ES cells were differentiated to Embryoid Bodies (EB) by hanging drop as previously 
described. The ES cells were harvested and cell density is determined in 2  104 cells/ml 
and hung in 20 l volume droplet on the cap of sterile, square dish (400 cells/drop). The 
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lids containing the droplets were inverted and placed back onto the base of the plate 
with10 ml of sterile water to maintain moisture/humidity content. The square dishes 
were maintained at 37C, 5% CO2 and at 95% humidity. Resulting EBs were collected at 
different times based on the experimental design. For single cell analysis, harvested EBs 
were trypsinized at 37C for five minutes if necessary. 
 
2.2 Normal Human Dermal Fibroblast and Reprogrammed Cell Culture 
Normal Human Dermal Fibroblasts (NHDF) were purchase from Lonza (CC-2509, 
Lonza) and cultured with FBM medium (CC-3131) supplemented with FGM-2 
SingleQuots (CC-4126). NHDF cells were cultured following the manufacturer’s 
recommendations and sub-cultured weekly. 
 
Reprogrammed cells were cultured in StemPro® hES SFM (A1000701, Invitrogen) and 
reprogrammed cardiac progenitors were grown with alpha MEM medium supplemented 
with 15% FBS, 0.1 mM β-mercaptoethanol, 2 mM glutamine (25030, Gibco) and 0.1 
mM nonessential amino acids (11140, Invitrogen). 
 
2.3 Lentivirus Production 
Lentiviruses were produced by 293FT cells. 293FT cells were grown under DMEM 
supplemented with 10% FBS (SH30910), sodium pyruvate (11360, Gibco), L-Glutamine 
(25030, Gibco), MEM-NEAA (11140, Gibco) and Penicillin-Streptomycin (15140 
Gibco). To produce lentivirus, 2.5  106 cells were seeded on 60 mm plate one day 
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before transfection. The next day, 4.5 g of lentiviral plasmid, 1.87 g of pMD2.G and 
2.8 g of psPAX2 were transfected to 293FT cell by FuGene HD (4709705001, Roche). 
Lentiviral particles were collected 24 to 48 hours after transfection and filtered with 0.45 
m filter following 0.22 m filter then stored at -80C until used. 
 
2.4 Quantitative Real-Time PCR 
RNA was isolated by RNeasy kit following the manual. To avoid genomic DNA 
contamination, on-column DNA digestion step was added during RNA isolation. RNA 
concentrations were determined by Spectrophotometer (NanoDrop 2000, Thermo 
Scientific). 2 g of RNA were used to perform reverse transcription by M-MLV reverse 
transcription kit (28025-013, Life Technologies) following the manufacturer’s 
recommended procedure. After the reverse transcription step, the cDNA samples were 
diluted to the final concentration of 10 ng/l for the qPCR reactions. Brilliant II SYBR 
Green QPCR Master Mix (600828, Agilent Technologies) was used to perform qPCR 
and reactions were run on HT7900 Real-Time PCR System (Life Technologies). The 
qPCR primers of each gene measured are listed in Table 1 and Table 2.  
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Table 1 Primer List of Mouse Genes 
Gene Forward Reverse 
Acvr2a TTCAAATCCTGTTACACCGAAGC AGGAGGGTAGGCCATCTTGTG 
Cxcr4 GAAGTGGGTTCTGGAGACTAT TTGCCGACTATGCCAGTCAAG 
Ehf TCAAATGGGAAGACCGTTCGG CCGGCTGAGCTTCTCGTAT 
Elf1 TGTCCAACAGAACGACCTAGT CACACAAGCTAGACCAGCATAA 
Elf2 GTTCACAGCAGTAATGCTCACT TCAAGCAGGTAGGAGATTCCAT 
Elf3 GCTGCCACCTGTGAGATCAG GTGCCAAAGGTAGTCGGAGG 
Elf4 CTGGAAGACCCTTCAGTGTTC GCACAAGGTCCTGTCCCTTATG 
Elf5 ATGTTGGACTCCGTAACCCAT GCAGGGTAGTAGTCTTCATTGCT 
Elk1 TCCTGGACCTCACGGGATG GGGTAGGACACAAACTTGTAGAC 
Elk3 TCCTCACGCGGTAGAGATCAG GTGGAGGTACTCGTTGCGG 
Elk4 ATCTAACAATGGGGAGTTCAAGC GGCTCGGCTGAGTTTATCATAAT 
Eomes CCCTATGGCTCAAATTCCAC AGAACCACTTCCACGAAAACAT 
Erf GGTTTGCCTTCCCAGATTGG CCTGGTACTCCTCTTTCCGAA 
Erg ACCTCACCCCTCAGTCCAAA TGGTCGGTCCCAGGATCTG 
Ets1 TCCTATCAGCTCGGAAGAACTC TCTTGCTTGATGGCAAAGTAGTC 
Ets2 CCTGTCGCCAACAGTTTTCG TGGAGTGTCTGATCTTCACTGA 
Etv1 TTAAGTGCAGGCGTCTTCTTC GGAGGCCATGAAAAGCCAAA 
Etv2 CTGGGAGCGGAATTTGGTTTC GTAAAGCGGGGTTCCAGTCC 
Etv3 ATGAAAGCAGGCTGTAGCATC ATGGCGGAACTCTTCCTTCTG 
Etv4 CGGAGGATGAAAGGCGGATAC TCTTGGAAGTGACTGAGGTCC 
Etv5 TCAGTCTGATAACTTGGTGCTTC GGCTTCCTATCGTAGGCACAA 
Etv6 AGCAGGAACGAATTTCATACACG GGCAGGTGGATCGAGTCTTC 
Fev ACGCCTACCGCTTTGACTTC AAGCTGCCATCAAGTTGAGTT 
Fli1 ATGGACGGGACTATTAAGGAGG GAAGCAGTCATATCTGCCTTGG 
Foxa2 TCCGACTGGAGCAGCTACTAC GCGCCCACATAGGATGACA 
Gabpa AGCGCATCTCGTTGAAGAAG TCCTGCTCTTTTCTGTAGCCT 
Gapdh AGGTCGGTGTGAACGGATTTG TGTAGACCATGTAGTTGAGGTCA 
Gata1 GCACTAACTGTCAAACGACCAC TCTGGATTCCATCTTTCCTCAT 
Gata2 CACCCCGCCGTATTGAATG CCTGCGAGTCGAGATGGTTG 
Gata4 CACGCTGTGGCGTCGTAAT CTGGTTTGAATCCCCTCCTTC 
Gata6 CTTGCGGGCTCTATATGAAACT TAGGTTTTCGTTTCCTGGTTTG 
Gsc CCCCGGTTCTGTACTGGTG TCTGGGTACTTCGTCTCCTGG 
Hand2 CTACATCGCCTACCTCATGGAT TGCTCACTGTGCTTTTCAAGAT 
Hhex CGGACGGTGAACGACTACAC CGTTGGAGAACCTCACTTGAC 
Isl1 ATGATGGTGGTTTACAGGCTAAC TCGATGCTACTTCACTGCCAG 
Mef2c ATGCCATCAGTGAATCAAAGGAT GTGGTACGGTCTCCCAACT 
Mesp1 GCTCGGTCCCCGTTTAAGC ACGATGGGTCCCACGATTCT 
Mesp2 GCCTAGGAACAAGACTGGACAC AGGGTTCTGGAGACACAGAAAG 
Mixl1 CATGTACCCAGACATCCACTTG CTTGAGGATAAGGGCTGAAATG 
Myocd ACCACTGAGCAATACCCCTCTA CGGATTCGAAGCTGTTGTCTTA 
Nkx2-5 GACAAAGCCGAGACGGATGG CTGTCGCTTGCACTTGTAGC 
Pdgfra GGAGACTCAAGTAACCTTGCAC TCAGTTCTGACGTTGCTTTCAA 
Pitx2 ACCCCGGCTATTCGTACAAC GAGGACAGGGGATTGACGTTC 
Sall4 TCCAACATTTATCCGAGCACAG TGGCAGACGAGAAGTTCTTTC 
Sfpi1 ATGTTACAGGCGTGCAAAATGG TGATCGCTATGGCTTTCTCCA 
Smad1 GCTTCGTGAAGGGTTGGGG CGGATGAAATAGGATTGTGGGG 
Smo CAATCGCTACCCTGCGGTTAT CTGCTCGGCAAACAATCTCTC 
Sox17 GATGCGGGATACGCCAGTG CCACCACCTCGCCTTTCAC 
Spdef AAGGCAGCATCAGGAGCAATG CTGTCAATGACGGGACACTG 
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Table 1 (Continued) 
Gene Forward Reverse 
Spib AGGAGTCTTCTACGACCTGGA GAAGGCTTCATAGGGAGCGAT 
Spic AAACATTTCAAGACGCCATTGAC CTCTGACGTGAGGATAAGGGT 
T GCTTCAAGGAGCTAACTAACGAG CCAGCAAGAAAGAGTACATGGC 
Tal1 CGGCAGCAGAATGTGAATGG CTCCTGGTCATTGAGTAACTTGG 
Tbx20 AAACCCCTGGAACAATTTGTGG CATCTCTTCGCTGGGGATGAT 
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Table 2 Primer List of Human Genes 
Gene Forward Reverse 
ACTA2 CGGTGCTGTCTCTCTATGCC CACGCTCAGTCAGGATCTTCA 
ACVR2B GCCTCTGGCAAATGAGTGAAG TTCAACTGCTACGATAGGCAGG 
CTNNB1 TACCTCCCAAGTCCTGTATGAG TGAGCAGCATCAAACTGTGTAG 
BMP2 ACCTTTATGGAGGGAAACCCA CCGGATCTGGTTCAAGCATGA 
BMP4 TGGTCTTGAGTATCCTGAGCG GCTGAGGTTAAAGAGGAAACGA 
CITED1 ACCAGCGACATCAGCACTTC GACCCCTGCAAAACTGGGAC 
CX43 AGAGGAAGAACTCAAGGTTGCC AGGCCACCTCAAAGATAGACT 
CX45 AAGATTGCCAAAATGGAGCACG CTCCTCCGTTTCTTCCAGAGC 
DKK1 ATTCCAACGCTATCAAGAACC CCAAGGTGCTATGATCATTACC 
FOXH1 GTCGTAGATGCTTTTGTTGGGT CTGCCCACCTCCTACTTGC 
GAPDH TGTTGCCATCAATGACCCCTT CTCCACGACGTACTCAGCG 
GATA2 CATCTTCATGCTCTCCGTCAG GGCCCACTCTCTGTGTACC 
GATA4 CATGGGCCCTCCATCCACCCTG CCTCCAAGTCCCAGGTCCGTGC 
GATA6 AGAAACGCCGAGGGTGAAC AGTTGGAGTCATGGGAATGGAA 
HAND2 ATGAGTCTGGTAGGTGGTTTTCC CATACTCGGGGCTGTAGGACA 
ISL1 GTGGAGAGGGCCAGTCTAGG CCGTCATCTCTACCAGTTGCT 
KDR GCACAAAGTGACACGTTGAGAT AGTGATCGGAAATGACACTGGA 
LEFTY1 CTGAGCAAGGGCTCTCCAGTGG AGCTGGCGATGACTGAACTGCTG 
MEF2B CACTGAGAGCGTCTACGTCCT CTGCATGTCTGCCTTGTGC 
MEF2C ATGGATGAACGTAACAGACAGGT CGGCTCGTTGTACTCCGTG 
MESP1 TCGAAGTGGTTCCTTGGCAGAC CCTCCTGCTTGCCTCAAAGTGTC 
MESP2 CGCTGCGCCTGGCCATCCGCTACAT GCCCCAAGGGGACCCCGCGAC 
MYL2 TTGGGCGAGTGAACGTGAAAA CCGAACGTAATCAGCCTTCAG 
MYL7 CAGCATAGATGATCGAGAGGAGC TAGGAGGTCCGAAGAGTTCAG 
MYH3 CAACAATCCCTACGACTACGC ACGTCAAAGGCACTATCGGTG 
MYH6 CACTGATAACGCTTTTGATGTGC TAGGCAGACTTGTCAGCCTCT 
MYH7 TTTGAACAAGCCCAGATACAGG CTCGGGGTCTGTCCCATTG 
NKX2-5 CCCTGACCGATCCCACCTCAAC GGCGGGCGACGGCGAGATAGC 
NOS2 TCATCCGCTATGCTGGCTAC CTCAGGGTCACGGCCATTG 
PDGFRA CCTGGTCTTAGGCTGTCTTCT GCCAGCTCACTTCACTCTCC 
PECAM1 GGAAAAGGCCCCAATACACTT TAAAACGCGGTCCTGTTCCTC 
SMAD2 CTCAAGCTCATCTAATCGTCCTG ATGTCGTCCATCTTGCCATTC 
SMAD3 ACGCAGACCTCGTCCTTCT GAACGTCAACACCAAGTGCAT 
SMARCD3 CCACCTCGTTGAGTGGCATC AGCCTGTTGGTCTTCACATACT 
SOX17 ACTCTGGCAGTCGCGGTAGTGGC GCGGCGCAAGCAGGTGAAG 
TAGLN2 CTGCTTGCAGGAACTGAGAGA ACCCAGTGCCGAAAGGATG 
TBX20 TCCAGATTCTCCTTTTACCG TTCAGACTTCAGGTTGAGCA 
TBX2 ACAGCTCACAGTGGATGGTAG GCACTCGGGGTTTGTACTTATG 
TBX3 TTAAAGTGAGATGTTCTGGGCTG ACTATAATTCCCCTGCCACGTA 
TBX5 CACTTCTCCGCTCACTTCACC TGGCACGCCATGAGAGTAGA 
TDGF1 AGATGGACGAGCAAATTCCTG AAGATGGCCCGCTTCTCTTAC 
TNNT1 TCTTCCGCTGCTCGAAATGTA TGATCCCGCCAAAGATCCC 
TNNT2 GAGTTGCAGGCGCTGATTG TCTGGATGTAACCCCCAAAATG 
WNT2 CCCCCGAGGTCAACTCTTC CTAATGGCACGCATCACATCT 
WNT11 CTGACCTCAAGACCCGATACC CGAGTTCCGAGTCCTTCACAG 
ZIC3 AGTAGCAGACGTGGTTGTTCT CGTTATATGCGGCAGCCTATC 
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2.5 Western Blot and Co-Immunoprecipitation 
RIPA buffer (50 mM Tris, pH8; 150 mM NaCl; 1% NP40; 0.5% Sodium Deoxycholate; 
0.1% SDS) supplemented with Protease Inhibitor Cocktail Tablet (05892791001, Roche) 
were used to lyse the cells. Generally, 107 cells were lysed by 1 ml of RIPA buffer on ice 
for 30 minutes then sonicated for 20 seconds to shear DNA if sample was viscous. The 
protein concentrations were determined by BCA Protein Assay Kit (23225, Pierce). 
Samples were denatured by boiling for 10 minutes with NuPAGE LDS Sample Buffer 
(NP0007, Life Technologies). Novex NuPAGE Gel Electrophoresis System was used to 
conduct Western Blotting follow the manufacturer’s instruction. Briefly, 10 to 50 g of 
protein was loaded onto a 4-12% Bis-Tris Protein Gel and separated by electrophoresis. 
The protein was transferred to PVDF membranes for 90 minutes then blocked with 5% 
TBST milk for an hour. The PVDF membranes were incubated with the primary 
antibody at 4C overnight gently rocking and secondary antibodies for an hour at room 
temperature the following day. Membranes were incubated with enhanced chemi-
luminescence (ECL) (NEL10400, Perkin Elmer) and visualized by X-ray film exposure.  
The information of each antibody was listed in Table 3. 
 
Co-Immunoprecipitation (Co-IP) was performed by the similar protocol of Western blot. 
The cells were lysed and Anti-HA Afftinity Gel (E6779, Sigma) or Anti-FLAG Affinity 
Gel (F2426, Sigma) were used for immunoprecipitation. Generally, 50 l of affinity gel 
were used to precipitate 1000 g of total cell lysate at 4C overnight. Samples were 
eluted by 0.1M of acetic glycine solution (pH 2.8) from affinity gel and 1M of Tris 
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buffer (pH 8.0) were used to neutralize the elution reaction. The eluted sample and total 
cell lysates were subject to Western blot as previously discussed. 
 
2.6 Flow Cytometry Analysis and Sorting 
Cells carrying endogenous fluorescence such as eGFP, eYFP or Nkx2-5-tdTomato 
reporter were harvested and dissociated by trypsinization and resuspended in culture 
media. Cells were subject to fluorescence analysis or Fluorescence-Activated Cell 
Sorting (FACS). Sorted cells were collected in regular culture media. 
 
Cells subjected to surface marker analysis were harvested and dissociated by 
trypsinization. Surface markers sensitive to trypsinization were harvested and 
dissociated by Accutase. Cells were resuspended at 1  105 cells/100 l in Fixation 
Buffer (R&D) for 10 minutes at room temperature. Centrifuged cells and decanted the 
Fixation Buffer and wash with PBS 2 times. Resuspended cells in 100 l of 
Fixation/Permeablization buffer and add 1-5 g/ml of primary antibody (follow the 
recommended dilution from manual) and incubated on ice in the dark for 30 minutes. 
Washed the cells with PBS 2 times and add fluorescence conjugated secondary antibody 
or fluorescence conjugated streptavidin (if biotinylated primary antibody were used) 
following the recommended dilution and incubated 20 minutes on ice in the dark. 
Washed the cells with PBS 2 times and resuspended with 500 ml of PBS and subject to 
flow cytometry. 
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Table 3 Antibodies Used for Western Blot, Co-IP, and Flow Cytometry 
Western Blot    
Name Manufactory Catalog Number Dilution 
Mesp1 Abgent AP16455c 1000 
Mesp1 Sigma SAB1302562 1000 
MESP1 Abcam ab77013 1000 
MESP1 Abcam ab171427 1000 
HA Covance MMS-101P 2000 
ACTC1 Abcam ab28052 1000 
TNNT2 Abcam ab8295 500 
MHC U of Iowa MF20 500 
TNNI3 Cell Signaling #4002 1000 
GAPDH Santa Cruz sc-20357 HRP 5000 
Rabbit IgG Santa Cruz sc-2301 5000 
Mouse IgG Santa Cruz sc-2302 5000 
    
     
Flow Cytometry   
Name Manufactory Catalog Number Dilution 
CD31 BD Pharmingen 558094 100 
CD31* BD Pharmingen 560984 100 
CD144 eBioscience 56-1449 100 
CD309 R&D Systems FAB357A 100 
CD309* BD Pharmingen 560872 100 
CD34 BioLegend 343523 100 
CD140a BioLegend 323503 100 
CD184 BioLegend 306504 100 
CD117 BioLegend 313208 100 
     
    
Immunofluorescence Staining  
Name Manufactory Catalog Number Dilution 
GFP Abcam ab6658 800 
Foxa2 DSHB 4C7 100 
Gata1 Santa Cruz sc-265 200 
Nkx2-5 Abcam ab35842 50 
Runx1 Santa Cruz sc-365644 200 
Pea3 Abcam ab70425 200 
 
* Antibody used in Islas, Liu, Weng et, al. PNAS, 2012; 109(32): 13016-21 
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2.7 Isolation of ChIP-Enriched DNA  
This procedure is ideally started with 10-20 million cultured cells; however, we also 
applied the same general method for starting with 100k cells. Cells were first fixed using 
1 % formaldehyde for 10 minutes and then quenched for 0.125 M glycine for 15 
minutes. Nuclei were isolated by washing the cell pellets with 5mM PIPES, 85mM KCl, 
and 0.5% NP-40 buffer and then spinning for 3 minutes at 3000rpm. A 1% SDS buffer 
was used for both nuclear lysis and subsequent sonication to shear the chromatin. For 
sonication with the Bioruptor UCD-300 sonicator, we used a 50-100µl volume/sample in 
1.5ml eppendorf tubes.  Sonication was performed for 15 cycles at 1 minute/ cycle. We 
performed 3 sets of 5 consecutive cycles on the "high" setting, which corresponds to 5W. 
The target size of sheared DNA was 200 to 300 bp. After shearing to the ideal size, 
sheared chromatin was diluted in ChIP-IP buffer and pre-cleared for 1 hour at room 
temperature with Protein-G Dynabeads from Invitrogen. 100uL of pre-cleared sheared 
chromatin was used per immunoprecipitation with a specific antibody for Mesp1. 
Samples were probed overnight at 4°C gently rocking. The following day samples were 
then incubated with Dynabeads conjugated with Protein-G from Invitrogen for 1 hour at 
4°C and 30 minutes at room temperature. Beads were then washed with Low and High 
salt washes and 2 final washes with Tris EDTA buffer before being eluted. Eluted 
samples were treated with RNAse and Proteinase K before being reverse cross-linked at 
65°C overnight. DNA was purified using Qiagen Minelute columns following the 
recommended protocol. Resulting DNA was quantified using the picogreen assay from 
Promega and the Quantifluor fluorometer. Mesp1 ChIP-DNA was obtained from both 
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eYFP + and negative cells from 4 biological replicate samples along with 3 replicate 
samples from undifferentiated UH3 cells. 
 
2.8 ChIP-Seq Libraries for Next Generation Sequencing 
Resulting DNA fragments isolated from above were then used to generate Next 
Generation Sequencing (NGS) libraries for the Illumina HiSeq platform. We used the 
NEXTflexTM ChIP-Seq kit from BIOO Scientific (5143-02) for generating paired end, 
barcoded libraries that could be multiplexed. NGS libraries were prepared following the 
manufacturer’s recommended procedure up to the final PCR step. The final library 
amplification was done using KAPA biosciences HiFi polymerase. Final libraries were 
cleaned up using Ampure XP bead purification from Beckman Coulter and eluted in 
water. Eluted libraries were quantified using Promega’s picogreen assay and Quantiflour 
fluorometer. Libraries were multiplexed and 30μL submitted for sequencing at a 1nM 
multiplexed concentration to MDAnderson’s DNA core facility. 
 
2.9 Sequencing Data Analysis 
Sequencing raw data were aligned to the mouse reference genome (Ensembl 67) using 
bowtie with parameters: -t -v 3 -a  -m 1 --best --strata. Duplicate and non-uniquely 
mapped reads were removed for downstream analysis. We used cisGenome to detect 
Mesp1 peaks. Similar to MACS (Model-based Analysis of ChIP-Seq), cisGenome 
applies a local Poisson background model and handles replicates. We used a local 
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Poisson P-value < 0.0001. We annotated the peaks into promoter (+/- 2kb within the 
TSS), integenic, intron, and exon. 
 
In order to identify enriched motifs, FIMO (Find Individual Motif Occurrences) was 
used to scan for presence of known motifs in peaks with P-value < 0.001. A logistic 
regression model was used to model the motif occupancy in the peaks against a 
background set of sequences obtained by shuffling the peak sequences. The Z-values 
obtained from the regression were used to rank the motifs. High values of Z-values 
correspond to motifs with high rank. 
 
2.10 RNA Isolation and NGS Library Preparation  
RNA was isolated from undifferentiated and FACS sorted UH3 cells Days 5-8 post-
differentiation. Cells were sorted as described above for EYFP+. Both the positive and 
negative populations were used for transcriptome analysis. RNA was extracted from 
250k cells for each group using the RNAeasy kit from Qiagen following the 
manufacturer’s recommended procedure. Following isolation the RNA was quantified 
using the Ribogreen quantification kit from Promega along with Promega’s Quantifluor 
fluorometer. 
 
A total of 100ng of the isolated RNA was used for generating the library for next 
generation sequencing using Illumina’s HiSeq platform. Libraries were prepared using 
the ScriptSeq Complete Gold kit from Epicentre (SCL24EP) following the 
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manufacturers recommended procedure for low input starting material. Final libraries 
were quantified using the pico-green quantification kit from Promega along with 
Promega’s Quantifluor fluorometer.  
 
2.11 RNA-Seq Data Analysis 
The raw reads from RNA-seq data were aligned to mouse genome (mm9) using bowtie 
and tophat2]. From the mapped reads, transcripts were assembled using cufflink. The 
abundances of transcripts are computed using cufflinks and expressed as FPKM 
(Fragments Per Kilobase of transcript per Million mapped reads). Assembled transcripts 
are obtained separately for 26 RNA-sequence samples (ES, Day 5, 6, 7 and 8 yfp+/yfp- 
samples). Using cuffmerge, the assembled transcripts from different samples are merged 
to obtain a unique list of assembled transcripts. To filter the annotated RNAs, annotated 
transcripts from UCSC genome browser (including the RefSeq genes) and Ensemble 
genome browser are obtained. Using cuffcompare, all annotated transcripts are removed 
from our unique list of assembled transcripts. After these steps, the remaining pool of 
transcripts is processed through a bioinformatics pipeline in order to remove transcripts, 
which are short or potentially protein coding. 
 
2.12 Luciferase Assay 
The Nkx2-5 promoter region was amplified from total mouse genomic DNA by PCR 
with specific primers to the region of interest. The promoter region was cloned into 
pGL3-Basic plasmid from Promega. HeLa or cos-1 cells were maintained by standard 
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protocol. The cell numbers were counted and found to be 1.8  105 cells/well and seeded 
into 24 well culture plate. Cells were transfected with 50 ng of pGL3-Nkx2-5 Luciferase 
reporter construct and 100 to 200 ng of activator plasmid. After 48 hours, the cells were 
harvested using 300 l of CCLR (Cell Culture Lysis Reagent). 100 l of substrate 
(E1500, Promega) was dispensed to 50 l of lysate and luciferase activities were 
measured with a luminometer (BD Monolight 3010). 
 
2.13 Immunofluorescence (IF) and Immunohistochemistry (IHC) Staining 
Mouse embryos for indicated stage(s) were dissected and embedded in paraffin. Samples 
were sectioned into 5 m sections using a microtome and subjected to 
immunofluorescence (IF) or immunohistochemistry (IHC) staining. Samples were 
rehydrated and sub-boiled for 10 minutes for antigens retrieval. The samples subjected to 
IF staining were incubated with primary antibodies at 4C overnight then incubated with 
corresponding fluorescence conjugated, secondary antibodies at room temperature for an 
hour in the dark. The antibodies used and the dilution factors were listed in Table 3. The 
sections were mounted with mounting medium containing DAPI stain (H-1500, Vector 
Laboratory).  
 
The samples subjected to IHC staining were incubated with biotinylated secondary 
antibodies for an hour at room temperature followed by horseradish peroxidase (HRP) 
conjugated streptavidin treatment for 15 minutes. DAB kit (SK4100, Vector Laboratory) 
was used to assess HRP activities. Sections were then dehydrated and then mounted onto 
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the glass slides. All images were taken using a Nikon Eclipse Ti Microscope and NIS 
Elements imaging software. 
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3. RESULTS 
 
3.1 Characterization of Mesp1 Expression Pattern 
To study Mesp1 function, the expression pattern needs to be known.  Previous studies 
demonstrated Mesp1 is expressed only during E6.5-E8.5 in mouse embryos and only in 
the testis in adult mice. Here, the immunofluorescence staining was used to show the 
protein expression profile in early mouse embryo (Figure 1A-D). Mesp1 was expressed 
in the extra-embryonic and posterior regions of the mouse embryo at E6.5. At E7.5 and 
highly expressed in the posterior part, primitive streak and the mesodermal /endodermal 
cross region. At E8.5, the expression intensity decreased and was detected only in the 
cytoplasm of the epicardium. When the mouse embryo reached to E9.5, most tissues and 
regions were not expressing Mesp1. This result showed the Mesp1 expression pattern 
and location during early mouse embryo development. 
 
The transient expression patterns were also observed in the mouse embryonic stem cell 
(ES cell or mESC) culture system. The mESC were differentiated by the hang drop 
method, an aggregating cell culture method to mimic embryo development. The qPCR 
data showed the expression profile from Day1 to Day10 (Figure 1E). Mesp1 only 
                                                 
 
 Part of the reported data of this section is reprinted with permission from Islas, J.F., et al., 
Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac 
progenitors. Proc Natl Acad Sci U S A, 2012. 109(32): p. 13016-21, Copyright [2012] by Proc 
Natl Acad Sci U S A. 
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expressed between Day3 to Day6 and peaks at Day4. Western blot also correlated with 
the qPCR data showing that the protein levels were about one day delay comparing to 
mRNA level (Figure 1F). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Expression Pattern of Mesp1 in Early Mouse Embryo and EB. 
(A)-(D) Immunofluorescence staining of Mesp1 at E6.5-E9.5 of mouse embryo by anti-MESP1 
antibody (ab77013, Abcam). (E) Fold Change of mRNA at different days of AB2.2 embryoid 
body. (F) Western blot of different days of embryoid body by anti-Mesp1 (AP16455c, Abgent) 
and anti-Gapdh antibodies. 
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3.2 Generation of Mesp1 Lineage Tracing ES Cell Lines 
To further understand what lineage population Mesp1 is contributing, a lineage tracing 
system was designed. Mice carrying Mesp1Cre/+ locus were crossed with Rosa26EYFP/+ 
mice and the resulting ES cells were isolated from inner cell mass of mice embryo to 
obtain an immortalized ES cell line named UH3. To be brief, when cells express Mesp1, 
it also expresses homologous recombinase Cre. The Cre recombinase then recognizes 
the flox sequence and excises the stop codon between two flox sites to allow eYFP 
permanent expression. UH3 cells were grown and maintained under standard ES culture 
conditions and were subject to differentiation by the aforementioned hang drop method. 
Once Mesp1 was expressed during differentiation, the eYFP allowed us to visually trace 
the population by fluorescence techniques (Figure 2A). Here flow cytometry was used to 
monitor the Mesp1-eYFP population. Similar to previous studies, UH3 cells were 
differentiated and EBs harvested on different days were analyzed by flow cytometry to 
characterize trace the lineage via a time series. The eYFP fluorescence expression started 
at Day4 and reached to 3-5% of the total cell population after Day5 (Figure 2B) while 
the percentage ration seemed not change through culture. These results showed the UH3 
cells marked the Mesp1 expressing population during differentiation and the eYFP 
allowed us to monitor and isolate the Mesp1 expressing population for further 
experiments. 
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 A 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
Figure 2 UH3 Cells Expressed eYFP After Differentiation. 
(A) Fluorescence microscopy of embryoid body at Day7 of UH3 cells showing eYFP. Scale bar 
is 100 m. (B) Flow cytometry analysis of different days of UH3 EB showing the percentages of 
eYFP population. 
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3.3 Identify Direct Targets of Mesp1 by ChIP-Sequencing 
To study the direct downstream targets of Mesp1, Chromatin Immunoprecipitation of 
Mesp1 bound targets followed by next generation sequencing (ChIP-seq) was 
performed. One of the major challenges to study Mesp1 targets was the transient 
expression of Mesp1 and the percentage of Mesp1 expressing cells in the overall 
population was small. Mesp1 expressed between Days 4 -7 and gave rise to only 5% 
within the entire EB cell population. To solve this problem, UH3 cells were used to trace 
the Mesp1 expressing population by monitoring the eYFP fluorescence. UH3 cells were 
differentiated by hanging drop method and FACS (Fluorescience-Activated Cell Sorting) 
sorting was performed at Day5. The eYFP positive population was collected for the 
Mesp1 ChIP experiment (Figure 3).  
 
 
A                                              B 
 
 
  
Figure 3 FACS Sorted eYFP Cells. 
(A) UH3 cells were differentiated by hanging drop and FACS sorting performed at Day 5. (B) 
Around 1-3% of total population of positive cells was sorted out. 
 
 
Another challenge of the ChIP technique in addition to the low cell number was the 
specificity of the antibody. A good antibody recognizes the target protein specifically 
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with minimal non-specific binding to eliminate false positive targets during the pull 
down step of ChIP experiment. To solve this problem, several commercial antibodies 
were tested by western blot and the optimal one (ab77013, Abcam) was chosen for the 
ChIP experiment (Figure 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 Commercial Mesp1 Antibody Comparison by Western Blot. 
UH3 cells were differentiated by hanging drop method and collect at different days. Four Mesp1 
commercial antibodies were used for western blot. To mark the accurate size of Mesp1 protein, 
293T cells were transiently transfected with constitutive Mesp1 expressing plasmid for 48 hours 
and cell lysates were subjected to western blot analysis. 
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The eYFP cells were FACS sorted and lysed for chromatin immunoprecipitation by the 
optimized Mesp1 antibody. The chromatin DNA was sheared to the optimal size ranging 
between 200 and 400 fragment sizes and subject to sequencing library preparation and 
Next Generation Sequencing. 
 
 
 
 
Figure 5 DNA Fragment Size Verification. 
UH3 cells were cross-linked with 1% formalin and chromatin was sonicated for 15 cycles with 
the Bioruptor UCD300 on the High setting. 50μL of sheared input chromatin sample was taken 
from total input sheared chromatin and treated with RNase A and Proteinase K and reverse 
cross-linked to release DNA bound fragments from proteins. DNA was cleaned up with a Qiagen 
DNA Minelute column and separated on a 2% Agarose gel by electrophoresis for 45 minutes at a 
constant 110V. 
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After Next Generation Sequencing, data were manipulated by software cisGenome. 
First, Gene ontology analysis was performed (Table 4). Within the top picked pathways 
from the GO analysis, we confirmed that Mesp1 targets were enriched in regulating 
developmental pathways including heart, vasculature, blood vessel, and epithelial cell 
development. Within the target list, many cardiac genes, such as Mef2c, Isl1, Tbx20 and 
Acvr2a, were direct targets of Mesp1 (Table 5). This suggests Mesp1 regulates cardiac 
development through these transcription networks. Not only did we find cardiac related 
gene targets but several endoderm genes, such as Gata6, Sox17, Foxa2, Pitx2 and Sall4, 
were also found to be direct Mesp1 targets. This suggests Mesp1 may have a role not 
only in cardiac mesoderm development but also in definitive endoderm development. 
Moreover, Mesp1 is also involved in early germ layer differentiation pathways such as 
meso/mesoendoderm development. This finding suggests Mesp1 may specify bi-potent 
populations and this population derives into both mesoderm and endoderm populations.  
 
3.4 Analyze Mesp1 Binding Motifs 
It is known that transcription factors recognize genomic DNA through conserved DNA 
binding motifs. Mesp1 is a basic helix-loop-helix (bHLH) transcription factor that 
recognizes DNA through the E-Box (CANNTG). Mesp1 ChIP-seq results were further 
analyzed through JASPAR database by comparing the existing motif from different 
transcription factors. Over a hundred existing motifs including Myc, Myod1, Hand1 and 
Runx1 were identified from JASPAR database (Table 6). The motif analysis showed the 
classical E-box (CANNTG) was identified in the list. It supports Mesp1 regulates the 
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Table 4 Gene Ontology Analysis of Mesp1 Target Genes from ChIP-Sequencing 
 Term ID Term P Value FDR 
BP GO:0007507 heart development 1.30E-07 2.47E-04 
BP GO:0001944 vasculature development 2.78E-07 5.27E-04 
BP GO:0051094 positive regulation of developmental process 3.28E-07 6.23E-04 
BP GO:0045941 positive regulation of transcription 6.64E-07 1.26E-03 
BP GO:0001568 blood vessel development 7.82E-07 1.48E-03 
BP GO:0045597 positive regulation of cell differentiation 5.38E-06 1.02E-02 
BP GO:0045165 cell fate commitment 7.17E-06 1.36E-02 
BP GO:0048568 embryonic organ development 8.38E-06 1.59E-02 
BP GO:0060429 epithelium development 6.69E-05 1.27E-01 
BP GO:0045449 regulation of transcription 4.97E-04 9.40E-01 
BP GO:0030324 lung development 2.19E-03 4.07E+00 
BP GO:0016055 Wnt receptor signaling pathway 4.93E-03 8.97E+00 
BP GO:0048762 mesenchymal cell differentiation 8.04E-03 1.42E+01 
BP GO:0048738 cardiac muscle tissue development 1.98E-02 3.16E+01 
BP GO:0003007 heart morphogenesis 2.92E-02 4.30E+01 
BP GO:0055010 ventricular cardiac muscle morphogenesis 3.12E-02 4.53E+01 
BP GO:0007512 adult heart development 3.51E-02 4.92E+01 
BP GO:0033077 T cell differentiation in the thymus 3.83E-02 5.24E+01 
BP GO:0002064 epithelial cell development 4.21E-02 5.59E+01 
BP GO:0048864 stem cell development 4.87E-02 6.13E+01 
BP GO:0001755 neural crest cell migration 4.87E-02 6.13E+01 
BP GO:0048863 stem cell differentiation 5.98E-02 6.90E+01 
BP GO:0060425 lung morphogenesis 7.64E-02 7.79E+01 
BP GO:0051145 smooth muscle cell differentiation 7.73E-02 7.83E+01 
BP GO:0045823 positive regulation of heart contraction 7.73E-02 7.83E+01 
BP GO:0007498 mesoderm development 9.43E-02 8.47E+01 
CC GO:0031012 extracellular matrix 1.28E-06 1.93E-03 
CC GO:0034704 calcium channel complex 7.39E-03 1.06E+01 
CC GO:0005667 transcription factor complex 4.94E-02 5.34E+01 
MF GO:0015267 channel activity 6.58E-10 1.12E-06 
MF GO:0022836 gated channel activity 1.86E-09 3.17E-06 
MF GO:0005509 calcium ion binding 1.65E-08 2.81E-05 
MF GO:0005249 voltage-gated potassium channel activity 1.86E-06 3.16E-03 
MF GO:0005244 voltage-gated ion channel activity 4.50E-06 7.66E-03 
MF GO:0022832 voltage-gated channel activity 4.50E-06 7.66E-03 
MF GO:0003700 transcription factor activity 7.98E-05 1.36E-01 
MF GO:0005262 calcium channel activity 7.07E-04 1.20E+00 
MF GO:0003712 transcription cofactor activity 5.27E-02 6.02E+01 
BP: Biological Process; CC: Cellular Component; MF: Molecular Function 
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Table 5 Target Genes in Mesp1 ChIP-Seq Results 
Acvr2a Acvr2b Bmp2 Bmp4 Cd34 
Cdh11 Celf1 Cited2 Cxcr4 Dkk1 
Dvl2 Ehf Elf2 Elf4 Elk3 
Erg Ets1 Ets2 Etv1 Etv4 
Etv5 Etv6 Ezh2 Fgf10 Foxa2 
Fst Gadd45a Gadd45b Gadd45g Gata6 
Gja1 Gli2 Gli3 Hand1 Hand2 
Hes1 Hey1 Hey2 Hif1a Id2 
Isl1 Mef2c Nkx6-1 Nppb Pax3 
Pdgfa Pitx2 Runx1 Runx2 Sall4 
Shh Smad2 Smad3 Smad4 Smarcd3 
Sox17 Tbx20 Tgfb2 Tgfbr1 Tgfbr2 
Tnnt2 Wnt3a Zic3   
 
 
downstream targets through binding to the conserved regions of these genes. The 
conserved binding regions also implied the potential factors within the same 
transcription complexes. 
 
3.5 Validation of Mesp1 Targets by Overexpressing Mesp1 
The ChIP-seq analysis revealed direct targets of Mesp1. The occupancy of certain 
genomic regions by transcription factors usually results in up or down regulation of 
transcription activities of downstream genes. It may also recruit the transcription 
complex to regulate the epigenetic pattern of these genes to change the transcription 
activities. Therefore it is necessary to measure the gene activity of downstream gene 
targets to understand the molecular mechanism behind how Mesp1 regulates 
downstream networks. 
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Table 6 DNA Binding Motif from Mesp1 ChIP-seq Results 
 
 
 
To answer this question, an inducible Mesp1 construct was generated and introduced 
into mES cells. AB2.2 ES cells were transduced a Doxycycline-inducible V5-Mesp1-
eGFP construct by lentiviral transduction. ES cells were cultured under standard 
procedure and Doxycycline was used (1 g/ml) to induce Mesp1 expression. Flow 
cytometry were used to monitor the eGFP expression after induction. Western blot were 
also perform to monitor the Messp1 and V5 protein expression (Figure 6).  
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Figure 6 Overexpressing Mesp1 by Doxycycline Induction in ES Cells.  
(A) Flow Cytometry showed ES cells expressed eGFP after Doxycycline induction. (B) Western 
blot showed Mesp1 and V5 were expressed after Doxycycline induction. 
 
 
After validating Mesp1 overexpression, ES cells were induced by Doxycycline and total 
RNA was isolated at indicated time points to analyze the gene expression. Quantitative 
real-time PCR showed the Mesoendoderm marker genes Gata6, Pitx2, Sox17, Foxa2, 
and Gsc were highly up regulated after 48 hours (Figure 7). Cardiac transcription factors 
such as Gata4, Hand2, and Myocd were activated after 24 hours of induction. Cardiac 
surface markers Cxcr4 and Pdgfra were also induced after 24 hours. These results 
confirmed that Mesp1 up-regulated the transcription activities of downstream target 
genes through genomic gene transcription activation.  
 
3.6 Gene Expression Characterization of Mesp1 Derived Cells by RNA-Seq 
Another way to confirm the ChIP-seq results was by monitoring the gene expression 
profiles in differentiating EB at the time that Mesp1 is expressed. UH3 mouse ES cells 
were used as a model to address this question. UH3 ES cells were differentiated by 
thehang drop method and the eYFP positive cells were subject to FACS sorting from 
Day5 to Day8. RNA was isolated and next generation sequencing was performed. This 
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Figure 7 Genes Regulated After Mesp1 Overexpression.  
Mesp1 were induced by Doxycycline (1 g/ml) treatment and sample were collected at indicated 
times. Quantitative realtime PCR were performed. Expression intensity was normalized by 
internal control Gapdh. Data represent relative expression comparing to undifferentiated ES cells 
as mean ± standard error of mean (SEM) from three biological triplicates. 
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allowed us to trace Mesp1 population and monitor genes regulated by Mesp1. The RNA-
seq results showed genes relative to germ layer specification such as Mesp1, Eomes, T, 
and Mixl1 were down regulated through differential days (Figure 8A). This implied that 
these genes would be negatively regulated once Mesp1 specified the progenitors. On the 
other hand, the cardiac genes such as Nkx2-5, Mef2c, Tbx5, and Gata4 were up-
regulated (Figure 8B). 
 
Interestingly, genes that were considered as endoderm markers, such as Sox17 and 
Foxa2, were not down regulated right after Mesp1 expression (Figure 8C). These results 
suggest that Mesp1 is not directly down regulated in endoderm development; instead, it 
might play roles involved in positively regulating other germ layer development. 
 
3.7 Mesp1 Contributes to Multiple Lineages  
The roles of Mesp1 during developmental processes were identified. However, did all 
Mesp1 committed cells differentiate to the same lineage? To answer this question, UH3 
cells were used as a lineage tracing model. Once UH3 cells expressed Mesp1, it also 
expressed eYFP permanently and eYFP protein can be recognized by anti-GFP antibody 
by using immunofluorescence staining. UH3 cells were differentiated by the hang drop 
method and EBs from samples were “dropped” or plated on Day5 and maintained 
through Day8. The samples were incubated with anti-GFP antibody and other antibodies 
that recognize different tissue specific markers. The results showed the markers from 
different germ layers were co-localized with GFP positive cells. CD31 is a surface 
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B 
 
 
 
 
 
 
 
Figure 8 Gene Expressions Profiling by RNA-Seq of Mesp1-eYFP Cells at Different Stages. 
(A) Germ layer specific genes were down regulated in later stage of EB. (B) Cardiac genes were 
up regulated in later stage of EB 
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Figure 8 (Continued).  
(C) Endoderm markers at different stage of EB showed these marker were not direct down 
regulated at Day5 and Day6. 
 
 
marker of endothelial cells and a majority of hematopoietic stem cells. Endoderm marker 
Foxa2 was also co-localized with GFP (Figure 9). This data suggested that Mesp1 
committed cells contributed to not only mesoderm but also endoderm tissue. Similar 
results can be confirmed in vivo (Figure 10). The immunofluorescence staining of 
sections in early mouse embryo showed GFP cells were present in the cardiac crescent. 
These results suggested that Mesp1 daughter cells contribute to mesoderm tissues such 
as heart, hematopoietic cells, endothelial cells and endoderm tissue(s) such as pancreas. 
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Figure 9 Immunofluorescence Staining of Embryoid Body by Different Lineage Markers. 
UH3 cells were differentiated and samples were fixed at Day6 and Day7. The scale bar is 100 
m. 
 
 
3.8 Identify the Association Partners of Mesp1 
Transcription factors regulate their downstream genes by binding to the regulatory 
regions such as promoter and/or enhancer regions on the genomic DNA. Theycan also 
form transcription complexes with histone modifiers or other transcription factors. The 
regulation of different downstream genes can be achieved by interacting with different 
interaction partners. Mesp1 is a bHLH transcription factor that may form a homodimer 
with itself or a heterodimer with other transcription factors. The biological functions of 
Mesp1 have been well characterized while the molecular details such as structural 
domain(s) and interaction partners are not well understood. Studying the interaction 
partners of Mesp1 will give us more information as to how Mesp1 regulates downstream 
pathways.   
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Figure 10 Immunofluorescence Staining of Different Lineage Markers in Mouse Embryo. 
(A) The co-staining of GFP and Nkx2-5 at E7.5 in sagittal orientation (B) The co-stianing of 
GFP and Foxa2 at E7.5 in sagittal orientation (Luo and Weng, manuscript in preparation). 
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Figure 10 (continued).  
(C) The co-staining of GFP and Nkx2-5 at E7.5 in sagittal orientation (B) The co-stianing of 
GFP and Foxa2 at E7.5 in sagittal orientation (Luo and Weng, manuscript in preparation). 
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In previous motif related studies several binding motifs of well known transcription 
factors such as bHLH transcription factors, Fox transcription factors, Gata transcription 
factors and ETS transcription factors have been revealed. This implies that Mesp1 may 
form transcription complexes with these transcription factors and the specific 
interactions may impact the regulation of downstream genes. Within these motif lists, 
Runx1 and ETS transcription factors are important markers for hematopoietic 
differentiation; Nkx2-5 is the most critical marker for cardiac mesoderm specification; 
Fox families are essential for endothelial cells differentiation. 
 
The protein-protein interactions can be confirmed by co-immunoprecipitation technique 
(Co-IP). Here, Mesp1 was overexpressed with other potential interaction partners. The 
results also showed Mesp1 interacting with several ETS factors including ETV1, ETV4, 
ETV7, ELF4, ELF5, and SPDEF (Figure 11). Although ETS transcription factors are not 
from the bHLH family, they were able to physically interact with Mesp1. This suggests 
Mesp1 may regulate some downstream target genes through interacting with ETS factors 
in different genomic locations or with respect to certain developmental time points. The 
detailed mechanism(s) needs further studies to support this theory. Most of the ETS 
factors play roles in hematopoietic differentiation such as the proliferation and 
maturation of B cells, T cells, NK cells, and lymphocytes. It implies the possible roles of 
Mesp1 during hematopoietic development. We also found most bHLH transcription 
factors that play roles in second heart field differentiation such as Hand1 and Hand2 
physical interacted with Mesp1. This provides supporting evidence that Mesp1 may 
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regulate cardiac differentiation through interacting with Hand2 and guide the maturation 
of cardiomyocytes. 
 
 
 
 
 
 
 
 
 
 
 
Figure 11 Physical Interactions of Mesp1 and ETS Transcription Factors.  
Co-immunoprecipitation of Mesp1 and ETS transcription factors showed ETV4, ETS2, ELF4, 
ELF5, ETV7 and SPDEF physical interact with Mesp1. Both Mesp1 and ETS factors were 
cloned into constitutive expression vector pcDNA3. ETS factors were designed to carry HA tag 
and Mesp1 were V5-tagged.Transfections of both Mesp1 and ETS factors in cos-1 cells by 
FuGene HD and sample were collected 48 hours after transfection. Cells were lysed by RIPA 
buffer and V5-conjugated agarose beads were used to precipitate interaction complex. Anti-
mouse IgG was used as control during precipitation process Western blot was performed after 
co-immunoprecipitation and anti-HA antibody was used. 
 
 
3.9 Characterization of the Gene Expression Profiles of Different ETS Factors 
The potential roles of ETS factors in cardiac development were identified previously. 
However the expressions of ETS factors were found to be ubiquitous. To narrow down 
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the factors that play roles specifically during cardiac development, screening through 
different stages of developmental processes were performed. Similar to Mesp1 
expression patterns in EB, qRT-PCR on different days of EB differentiation were 
performed to understand the expression profiles of ETS factors (Figure 12). The results 
showed the factors ETV4, ETV5, and SPIB were enriched in undifferentiated ES cells or 
in the early stage of EB differentiation while other factors such as ETS1, ETS2 and FLI1 
were up regulated in EBs during later stages. Still, others such as ERG and SPDEF were 
found to express only in a short time frame.  
 
The qRT-PCR data showed the expression profiles of ETS factors in EB in a temporal 
manner. The mesoderm formation occurs in very early embryonic stages. Therefore 
characterizing ETS factors in early developmental stages becomes important. Using ETS 
antibodies unique to individual ETS family members, we were able to perform 
immunofluorescence staining. At E6.5, ETV4 was present in the blood islands, 
mesoderm and endoderm (Figure 13). At E7.5, the ETV4 expression was present in the 
posterior region and migrates through the mesoderm layer toward the anterior region. 
This result suggested that although ETV4 expression intensity decreases through 
development, it was still detectable in early embryonic stages and may play roles in early 
mesodermal development.  
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Figure 12 Gene Expression Profiles of ETS Transcription Factors In Embryoid Bodies.  
Mouse ES cells were differentiated by the hang drop method and samples were collect at 
indicated times. Quantitative Real-time PCR was performed to measure mRNA expressed 
normalized to the internal control, Gapdh, and compared to undifferentiated ES cells. Data were 
presented as mean  standard error of mean from three biological replicates. 
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Figure 13 Immunofluorescence Staining of ETV4 in Early Mouse Embryo.  
Mouse Embryo At E6.5 was sectioned in sagittal orientation and stained ETV4 (red) and Mesp1 
(green). 
 
 
3.10 Combinatorial Regulation of ETS Transcription Factors and Mesp1 
The ETS factors’ expression profiles helped us to understand which ETS family 
members may play roles in regulating the development of cardiac progenitors along with 
Mesp1. Next, molecular and functional studies were needed. Luciferase assays were 
carried out to answer these questions. Our previous study showed Nkx2-5 playing a 
critical role in cardiac crescent specification. Moreover, the lacZ staining showed the 
enhancer region, which is -3000 base pairs upstream of the transcription start site, is the 
most critical region during heart development. It is highly acetylated during heart 
formation which means Nkx2-5 is controlled through this enhancer region. This Nkx2-5 
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enhancer region was cloned into a luciferase reporter construct to study what is 
regulating its transcriptional activity. The results showed both ETS2 and Mesp1 
increased the transcription activity of Nkx2-5 (Figure 14). The rest of the ETS factors 
showed only marginal activation via this enhancer region. Interestingly when combining 
Mesp1 expression with other ETS factors, some of them showed additive effects such as 
ETV4, ETV7 and SPDEF. It implied ETS transcription factors might regulate cardiac 
gene Nkx2-5 synergistically along with Mesp1. This result helped us to focus on those 
factors that were able to activate Nkx2-5 through the specified enhancer region, which 
may further activate the cardiogenesis pathway. 
 
3.11 Gene Regulation by Overexpressing ETS Factors 
To better study the biological function(s) of ETS factors, gain-of-function studies were 
conducted. In this study, Normal Human Dermal Fibroblast (NHDF) cells were chosen 
as our model system, and it was also chosen for performing reprogramming experiments. 
First of all, we cloned the ETS factors into a lenti-viral plasmid system and 
overexpressed these genes by lentiviral transduction. The cells were cultured for seven 
days to allow expression of ETS factors and responding genes. The RNA was isolated 
from these cells and cDNA microarrays were performed. The microarrays showed 
groups with differential gene expression regulated by ETS factors (Figure 15). The genes 
were clustered by their definition of germ layer differentiation. From the clustered heap 
map, ETV4 and ETS2 shared the most similarity in mesoderm and endoderm 
development.  
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Figure 14 ETS Factors and Mesp1 Activate Nkx2-5 Luciferase Activity. 
Equal amount of both Mesp1 and ETS factors were transfected into HeLa cells by FuGENE HD. 
Samples were collect and analyzed 48 hours after transfection. Data were presented as mean  
standard error of mean from three biological replicates. 
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Figure 15 Genes Regulation After Overexpressing ETS Factors. 
(A) Protocol used to overexpress ETS factors in NHDF. (B) Differential genes regulated by 
different ETS factors. (C) Cluster heat map showed the genes regulated by ETS factors. 
 
 
3.12 Characterization of Cell Surface Marker Expression after ETS Factor 
Overexpression  
Another way to characterize the cell population was by the cell surface markers. Cell 
surface markers were Cluster of Differentiation (CD) expressed on cytoplasm 
membranes that are either receptors for corresponding signal cascade or adhesion 
molecule to determine cell adhesion or migration. Previous results showed ETS factors 
activated essential genes for cardiogenesis. Here the surface markers CD31 (PECAM), 
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CD34, CD117 (c-kit), CD140a (PDGFRa), CD144 (VE-Cadherin), CD184 (CXCR4) 
and CD309 (Flk-1, KDR) were chosen to analyze the reprogramming effects (Figure 
16). 
 
The results showed Mesp1 activates surface markers that include CD34, CD140a, 
CD184 and CD309. ETV4 was shown to activate CD31, CD34, CD144, CD184 and 
CD309. When we combined ETV4 with Mesp1, we found ETV4 and Mesp1 additively 
activated CD31 from 5% to 7% a 2% increase in this surface marker within the total cell 
population. ETV4 and Mesp1 activated CD184 3.4% and 6.9% respectively but 
increased to 7.5% when combined. This result suggests the ETS factors and Mesp1 were 
capable of activating critical cardiac markers CD31 and CD184. It also supports the 
concept of the combinatorial regulation by ETS transcription factors and Mesp1. 
 
3.13 Reprogramming of NHDF by Introducing Mesp1 and ETS Factors 
Our studies revealed the expression pattern, physical interactions, and biological 
functions of Mesp1 and ETS factors. The next step was introducing Mesp1 and the ETS 
factors into somatic cells to see whether they beneficially regulate the genes necessary 
for cardiogenesis, most importantly, to see if differentiated cells can be converted into 
another cell fate. In order to reprogram the somatic cells, the commercially available 
Normal Human Dermal Fibroblast from Lonza was chosen. This eliminated the variation 
between different samples during the isolation process and avoided cell contamination 
issues.   
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Figure 16 Flow Cytometry Analysis Of Surface Marker in Reprogrammed NHDF. 
Specified transcription factors were transduced into NHDF by lenti-viral infection. Samples were 
harvested at Day 7 post transduction and stained with indicated surface markers for FACS 
sorting.  
 
 
To ensure proper gene delivery, Mesp1 and ETS factors were cloned into constitutive or 
Doxycycline-inducible lenti-viral plasmid constructs. Once the cells were transduced, 
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the cells can be isolated to ensure protein expression. This enabled the cells to be 
cultured for the long-term process required for cell conversion. 
 
To trace the conversion efficiency, an Nkx2-5 tdTomato reporter was used to monitor 
the reprogramming progress. Our previous research suggested the expression of Nkx2-5 
during heart formation in early mouse embryo was regulated by the acetylation of the 
enhancer region between -3000 and -2500 base pairs upstream of the transcription start 
site. This region was used to develop a fluorescence reporter to monitor Nkx2-5 
expression lifetime and therefore an internal marker that allowed us the physically 
follow the conversion progression. 
 
The NHDF cells were maintained in normal growth conditions. The NHDF cells were 
infected with the lenti-viral particles carrying Mesp1 and ETS factors (ETV4 and ETS2 
in this part) once cell confluency reached 80%. After infection, the media was changed 
to cardiac media alpha-MEM and cells were maintained until ready for analysis. One 
week post-infection, the morphologies of the NHDF cells changed from long hair like 
fibroblasts to epithelial shaped cells or rounded cells (Figure 17). The cells also 
expressed the tdTomato fluorescence reporter indicating the cells had activated and were 
expressing Nkx2-5. However the cells did not form mature and beating cardiomyocytes. 
This result suggested that using lenti-viral particles to convert NHDF cells was possible, 
but the protocol needed further refinement and optimization in order to achieve beating 
cardiomyocytes.  
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Figure 17 Reprogramming of NDHF by Mesp1 and ETS Factors.  
(A) Contrast images showed NHDF in Day0 and Day7. (B) Contrast and fluorescence images 
showed NHDF transduced with ETS2 in Day 14. (C) Contrast and fluorescence images showed 
NHDF transduced with ETV4 and Mesp1 in Day14 
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3.14 Reprogramming NHDF Into Cardiac Progenitors by ETS2 and Mesp1 
The reprogramming of adult cells toward other cell lineages requires not only 
endogenous gene expression but also environment cues such as cytokine treatments and 
culture conditions. After screening all ETS factors, ETS2 was chosen to reprogram the 
NHDF. Similar to previous part, the NHDF was transduced with lentiviral particles 
containing Mesp1 and ETS2. The results showed ETS2 converted the cells into rounded 
cells within one week (Figure 18). The cell surface markers also expressed CD31 and 
CD309. Quantitative real-time PCR also showed the cardiac genes NKX2-5, MEF2C, 
FLK1, PECAM and TDGF were highly expressed in the reprogrammed cells. These 
results showed ETS2 and Mesp1 successfully reprogrammed NHDF cells into another 
cell type specifically into cardiomyocytes. 
 
3.15 Addition of Activin A and BMP2 Increases the Reprogramming Efficiency 
The conversion of NHDF cells into replicating stages was achieved by transducing 
Mesp1 and ETS2. However, the cells seemed not to be able to form fully mature 
cardiomyocytes. It was reported the maturation of cardiomyocytes required the 
inhibition of the Wnt signaling pathway such as adding Activin A and BMP2. The 
continued expression of differentiation genes, ETS2 and Mesp1, was also not beneficial 
to the maturation of cells. Therefore a Doxycycline inducible system was designed to 
control the activation of these genes to only the early stages. Similar to the previous 
protocol, the lenti-viruses carrying ETS2 and Mesp1 were infected into NHDF cells but 
under an inducible promoter. These cells were treated with Doxycycline for four days.  
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B                                       C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18 ETS2 and Mesp1 Induce NHDF into KDR Positive Cells.  
(A) Protocol used to reprogram NHDF. (B) Morphology change of NHDF after reprogramming. 
(C) Flow cytometry analysis showed reprogrammed cells expressed CD31 and CD309. (D) Heat 
map of qPCR results showed gene expression profile after reprogramming. Data modified from 
Islas, Liu, Weng, et al. PNAS, 2012; 109(32): 13016-21. 
 
 
Following this, Activin A and BMP2 were then added for another 2 days. Cells were 
collected at Day 8 and subject to multiple analyses. The results showed two days of 
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Activin A and BMP2 treatment reached the optimal tdTomato fluorescence expression 
of Nkx2-5 reporter (Figure 19). Quantitative real-time PCR also showed the cardiac 
genes NKX2-5, GATA4, HAND2, and TNNT2 were the most highly expressed in 
combination of ETS2, Mesp1, Activin A, and BMP2.  
 
 
A 
 
B                                           C 
 
 
 
 
 
 
 
Figure 19 Activin A and BMP4 Treatment Induced NHDF into Cardiac Progenitors. 
(A) Schematic showing the culture conditions during the reprogramming process. (B) 
Fluorescence of reporters indicative of the reprogramming progress.  (C) The qPCR of core 
cardiac genes expression in combination of ETS2, MESP1, Activin A and BMP2. Data modified 
from Islas, Liu, Weng, et al. PNAS, 2012; 109(32): 13016-21. 
 
 
3.16 TAT-Protein Treatment Reprogrammed NHDF Cells into Cardiac Progenitors 
The lentiviral treatment was suitable for basic research purposes because of their high 
transduction efficiency. However, the leakiness of gene expression may result in 
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unwanted and long term expression of proliferating genes and was shown to not benefit 
to differentiation process. It may also result in oncogenic like consequences if the genes 
were constitutively expressed. To solve this problem, we designed a TAT-protein 
delivery system. Both ETS2 and Mesp1 were cloned into TAT-protein plasmids, and the 
proteins were purified from bacteria. The TAT-proteins were delivered to NHDF 
sequentially and similar cell converting was observed. The results showed the surface 
markers CD31 and CD309 were expressed (Figure 20). The qRT-PCR results showed 
essential cardiac genes were activated. Western blot analysis also confirmed the protein 
expression of cardiac structural proteins such as MHC and TNNI3. Long term culture 
experiments showed the cells formed mature sarcomeric structures. These results 
showed that transient treatments of ETS2 and Mesp1 along with the addition of Activin 
A and BMP2 were able to convert the NHDF cells and could increase the maturation 
process. This novel treatment and long term culturing methods the NHDF cells 
eventually were able to form mature sarcomeric cardiomyocytes. 
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Figure 20 TAT-Protein Induced NHDF into Cardiac Progenitors.  
(A) Schematic protocol for reprogramming by TAT-protein (B) Phase contrast image showed the 
converting of NHDF. (C). The converted cells expressed NKX2-5 tdTomato fluorescence. (D) 
Flow cytometry analysis showed the NKX2-5 tdTomato expression. (E) The 
immunofluorescence staining of sarcomeric a-actin (F) The flow cytometry analysis showed the 
cells expressed CD31 and CD309 (G) Western blot showed the core cardiac genes expression in 
NKX2-5 tdTomato enriched population. (H) Heat map of qPCR results showed the core cardiac 
gene expression in converted cells. Data modified from Islas, Liu, Weng, et al. PNAS, 2012; 
109(32): 13016-21. 
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4 DISCUSSION AND CONCLUSION 
 
4.1 Discussion 
4.1.1 The Expression Pattern of Mesp1 Can Be Further Studied 
Previous studies demonstrated E8.5 was the last stage of mouse embryo development 
that the mRNA of Mesp1 can be detected by in situ hybridization. Our 
immunofluorescence staining showed Mesp1 protein was elevated at E6.5 and E7.5 and 
barely detectable at E8.5 and E9.5. Interestingly, the staining at E7.5 showed the 
localization of Mesp1 in some cells was located in cytoplasm, not in the nucleus. Mesp1 
is a transcription factor and is considered to be functional in nucleus. Whether Mesp1 
localized in the cytoplasm has any functional implications is interesting and should be 
characterized in future studies.  
 
The Mesp1 lineage tracing system allowed us to answer the question of what are the 
Mesp1 derived tissues. It has been considered that Mesp1 leads to driving regions of the 
heart. However, our immunofluorescence staining showed tissues derived from 
endoderm such as pancreas also stained positive for Mesp1 in addition to those resulting 
from mesoderm. This finding suggests the roles of Mesp1 during development are not 
just involved in mesoderm development but also endoderm specification. Mesp1 may 
specify a bi-potent lineage and this lineage may contribute to both heart formation as 
well as endoderm tissues. 
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Another possibility is Mesp1 is reactivated in a later stage of embryonic development. 
Pancreas development occurs after E10.5 and Mesp1 could be expressed in those stages. 
Our results showed that Mesp1 is expressed between E6.5-E8.5 but further staining of 
later embryonic stages will be needed to answer this question. 
 
4.1.2 The Mesp1 Binding Site Validation along with Further Investigation of Non-
Coding Gene Targets  
The Mesp1 ChIP-seq results were carried out using an endogenous Mesp1 specific 
antibody on Mesp1 eYFP population from UH3 cells. One of the challenges was Mesp-
eYFP are only three to five percent of the total population. The low cell count made it 
difficult to isolate enough genomic DNA for generating a sequencing library. Therefore, 
the enriched signals from the sequence data were harder to determine compared to a 
more robust sample like a histone marker. This increased the chance of false positive 
targets. To solve this issue, regular ChIP-PCR should be performed to validate the 
targets we identified. We also used different antibodies specific to Mesp1 from different 
companies targeting unique epitopes of Mesp1 and compared the results. Those targets 
appearing as significant between both data sets were scored with a higher confidence 
since they overlapped. 
 
One of the advantages of the next generation sequencing is that the results include all 
enriched binding regions including those associated with non-coding genes. It has been 
the general opinion that transcription factors regulate downstream targets through 
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binding on the promoter or enhancer region and recruiting the transcription complex to 
alter or control the transcription activity. The next generation sequencing allows us to 
identify the regulation region in unbiased way. Our sequencing results suggested most of 
the binding regions of Mesp1 localized in non-coding area. This suggests Mesp1 could 
regulate non-coding genes such as miRNAs or lncRNAs (long non-coding RNA). One of 
the examples in our previous study showed SRF drove miR-210 expression that 
regulated cardiac development through the Shh signaling pathway. It would be 
interesting to identify the regulatory miRNA families and potential lncRNAs involved in 
cardiac differentiation that are also downstream targets of Mesp1.  
 
4.1.3 Characterization of Mesp1 Binding Partners  
Our studies showed Mesp1 is necessary for to not only mesoderm but also endoderm 
lineage specification. How Mesp1 specifies multiple lineages becomes one of the most 
interesting topics. During embryonic development, Mesp1 daughter cells may receive 
different developmental signals such as Wnt or BMP signal gradients with respect to 
their physical location and polarity within the developing embryo. The other possibility 
as to how Mesp1 contributes to different lineages is by interacting with different binding 
partners that lead to different or altered regulation of certain downstream genes. 
Therefore, to identify the interaction partners of Mesp1 in developmental stages could 
help solve this mystery. One way to achieve this is to pull down the interaction 
complexes at different stages of embryoid bodies post-differentiation using a Mesp1 
specific antibody and performing Mass Spectrometry analysis to identify the co-
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immunoprecipitated proteins that were bound to Mesp1. This information will further 
reveal the molecular mechanism(s) as to how Mesp1 guides committed cells toward 
maturation stages. It also helps us to understand whether there are combinatorial 
regulation elements.  
 
4.1.4 Study the Molecular Mechanism of Regulation of Mesp1 
One of most interesting characteristics of Mesp1 is that it is expressed in a very narrow 
time frame during developmental stage or it is transiently expressed at a specific time 
and is not expressed outside of the specific time frame. How to control its expression 
and how to down-regulate the transcription and degrade Mesp1 protein is another 
interesting topic. The repression of gene transcription can be achieved at the genomic 
and at post-transcriptional levels by genomic repression of the enhancer and/or promoter 
region, histone methylation, and/or miRNA inhibition. Identifying potential regulating 
factors such as downstream transcription factors or histone modifiers can help us 
understand how Mesp1 expression is so tightly regulated endogenously. Second, 
searching potential miRNA binding sites on Mesp1’s 3’untranslated region (UTR) will 
provide a starting list of miRNAs that are regulating Mesp1 post-transcriptionally by 
blocking translation. 
 
Another way to regulate signalling pathways is by post-translational regulation. One 
example is the Notch signal pathway. This signaling cascade needs to be switched 
quickly during somitogenesis. It was shown that Mesp2 can repress Notch signalling 
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pathway by forming a heterodimer with Maml1 and causeing subsequent Maml1 
degradation through proteasomal degradation. Protein degradation is more efficient 
compared to RNA repression in that it elicits a much faster cellular response. Is it 
possible that Mesp1 can be degraded by proteasomal degradation through interacting 
with certain protein binding partners? What interaction partners can cause Mesp1 
destabilization and what and where is the degradation recognition domain on Mesp1? 
This molecular mechanism can help us to explain the transient expression of Mesp1 and 
how the developmental timing in regulating Mesp1 can be so specific. It also helps us to 
extend the half-life of Mesp1 if Mesp1 protein is needed for clinical purposes. 
 
4.1.5 Multiple Roles of ETS Factors  
There are twenty-seven ETS transcription factors in the ETS family. They share the 
same conserved DNA binding site while regulating unique gene sets. The Nkx2-5 
luciferase assay provided a fast screening method to understand their potential roles in 
cardiac development. Microarrays in NHDF also provided an overview of changes in 
global gene expression patterns implicating different regulatory pathways in adult 
fibroblasts. However the mechanism involved in how individual factors play different 
roles with respect to time and location need to be achieved by further studies. Gain-of-
function and loss-of-function studies are the best ways to answer the signal pathways 
they are involved with. The deletion of a single ETS factor in a mouse model results in 
different phenotypes. For example, loss of Spi1, Spib, and Fli1 leads to defective B cells. 
Loss of Elf4, Elk4, and Ets1 causes T or NK cells to be defective. Loss of Etv6, Etv2, 
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and Erg leads to faulty hematopoietic stem cell development. How these ETS factors 
coordinate the transcription networks with Mesp1 to guide mesoderm development such 
as heart formation and hematopoietic stem cell maturation would be an interesting field 
to study. 
 
4.1.6 Combination of ETS Factors or Other Cardiac Genes to Reprogram Cells into 
Cardiac Progenitors 
Our data showed the effect of individual ETS factors on NHDF cells such as gene 
expression and cell surface marker profiling. It seemed ETS2 and ETV4 were able to 
reprogram these cells into the cardiac lineage the best among the entire set of ETS 
factors that we screened. However, whether a single gene is sufficient or a combination 
of more than two factors may work better is still unexplored. There was a report that 
showed the deletion of ETV1, ETV4 and ETV5 leads to a complete absence of heart 
tissue in Zebra fish. The deletion of both Mesp1 and Mesp2 also showed a loss of 
cardiac formation while a single deletion of Mesp1 only led to cardia bifida. The 
function of Mesp1 can be compensated by Mesp2 in early cardiac mesoderm 
specification. The function of a transcription factor can be compensated by another, 
factor from the same family in some cases. Therefore, it is worth trying various 
combinations of ETS transcription factors that are in the same sub-family to see which 
members are acceptable replacements for others. 
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4.1.7 Reprogramming Human Adult Cells into Cardiac Progenitors 
More and more studies provide evidence that shows switching of terminally 
differentiated cells into another fate is practical. Introducing transcription factors such as 
Gata4, Mef2c, Tbx5, and Hand2 converted fibroblasts into cardiomyocytes in vitro and 
in vivo in mouse models. By adding miR-1 and miR-133 to the previous recipe 
successfully converted neonatal foreskin into cardiac cells. A recent report showed that 
stressful environments such as a low pH bath can also convert cells into stem-like cells 
even more efficiently.  
 
The concept of reprogramming adult cells is more and more accepted in the scientific 
community. However, the reprogramming processes usually take at least a week to a 
month to reach mature and beating cardiomyocytes. It becomes a big challenge to 
reprogram sufficient cells in a short time for clinical usage. A second concern is that the 
reprogrammed cells from patients are assumed to maintain the same major 
histocompatibility complex (MHC). However, there is a report showing the MHC will 
alter after the reprogramming process. It is critical to evaluate the MHC in 
reprogrammed cells before launching any clinical studies. A third concern is to control 
proliferating cells from forming teratomas. The pluripotent cells transplanted into 
animals may derive to all three germ layers and become a teratoma, which is not 
beneficial to repair and creates more problems than it solves. Although we showed the 
ETS and Mesp1 derived cells may contribute to mesoderm and endoderm, no evidence 
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showing ectoderm programs was observed. This needs to be further confirmed by in vivo 
studies to prevent any oncogenic issues that may arise.  
 
4.2 Conclusion 
Mesp1 has been considered to play the top hierarchal role during cardiogenesis. Our 
studies provide a detailed mechanism from multiple molecular approaches. The Mesp1 
expression pattern in early mouse embryo was first revealed. The protein expression 
starts from the posterior region of E6.5. At E7.5, Mesp1 migrates toward the anterior 
embryonic region from the primitive streak. It migrates and contributes to the mesoderm 
layer and our newly discovered endoderm layer. By E8.5 and afterward, Mesp1 is not 
significantly detectable. Similar results were demonstrated in both mRNA and protein 
levels in embryoid bodies in vitro. 
 
A Mesp1 lineage tracing ES cell line was also established and characterized. By using 
this cell line, we were able to purify the Mesp1 expressing population by flow cytometry 
and able to perform next generation sequencing with Mesp1 specific, endogenous 
antibody. The sequencing results confirmed the developmental roles during 
cardiogenesis. Mesp1 target genes involved in cardiac development included Gata4, 
Myocd, Hand2, and Cxcr4 and these were confirmed with a Mesp1 over-expressed 
system. Moreover, the results suggested Mesp1 also regulates genes in endoderm 
development such as Foxa2, Gata6, and Pitx2. The lineage tracing ES cell line 
confirmed the endoderm marker Foxa2 was present in Mesp1 daughter cells. We showed 
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Mesp1 expresses in early mesoderm and endoderm and provided the information of the 
binding region of downstream targets. 
 
The roles of the ETS family of transcription factors were focused on oncogenic 
processes of tumor formation and the development of hematopoietic cells. We showed 
the expression pattern in cardiac development via embryoid body development. Some 
ETS factors such as ETS2, ETV4, and SPDEF could physically interact with Mesp1 and 
up-regulated Nkx2-5 transcription activity. By transducing ETV4 or ETS2 with Mesp1 
in human fibroblast cells led to up-regulation of essential genes for cardiogenesis such as 
GATA4, NKX2-5, MEF2C and TNNT2. ETV4 and ETS2 also up-regulated the cell 
surface marker CD184 (CXCR4). The screening of ETS factors provided their roles 
during cardiogenesis and this information could benefit to the reprogramming process of 
adult cells to be utilized in the future. 
 
The reprogramming of adult cells toward other cell types requires genes activation and 
culture conditions. In our studies, introducing ETS2 and MESP1 by lentiviral particle 
infection or TAT-protein delivery and combining Activin A and BMP2 treatment was 
able to convert NHDF cells into cardiac progenitors. The reprogrammed cells were 
evaluated through the characterization of gene expression, surface marker presence, 
along with structural proteins and overall cell morphology.  
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To sum up, our studies provided detailed information of the molecular regulation of 
Mesp1 and ETS transcription factors during early cardiac development. Through 
understanding the transcriptional machinery, we further manipulated adult cells and 
evaluated the reprogrammed cells by multiple approaches. This work helps to solve how 
cardiac progenitors are regulated and provided a method for reprogramming adult cells 
for future clinical applications that could be used not only in cardiac related applications 
but also in other non-cardiac tissues such as the pancreas for treating disease such as 
diabetes. 
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APPENDIX 
 
Working Model of Regulation of Mesp1 and ETS Transcription Factors 
The schematic shows the working model of how Mesp1 coordinating with ETS 
transcription factors to regulate cardiac progenitors. 
 
 
 
Figure A1 The Working Model of Regulation of Mesp1 and ETS Transcription Factors  
 
 
